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Clostridium	  difficile	  is	  a	  frequent	  source	  of	  healthcare-­‐associated	  infection,	  especially	  among	  patients	  on	  antibiotics	  or	  proton	  pump	  inhibitors	  (PPIs).	  The	  rate	  of	  C.	  difficile	  infection	  (CDI)	  has	  been	  steadily	  rising	  since	  2000	  and	  now	  represents	  a	  major	  burden	  on	  the	  healthcare	  system	  in	  terms	  of	  both	  morbidity	  and	  mortality.	  However,	  despite	  its	  public	  health	  importance,	  there	  are	  few	  mathematical	  models	  of	  C.	  difficile	  which	  might	  be	  used	  to	  evaluate	  our	  current	  evidence	  base	  or	  new	  control	  measures.	  
Three	  different	  data	  sources	  were	  analyzed	  to	  provide	  parameters	  for	  a	  mathematical	  model:	  a	  cohort	  of	  incident	  CDI	  cases	  in	  the	  Duke	  Infection	  Control	  Outreach	  Network	  (DICON),	  a	  hospital-­‐level	  surveillance	  time	  series,	  also	  from	  DICON,	  and	  inpatient	  records	  from	  UNC	  Healthcare,	  all	  from	  7/1/2009	  to	  12/31/2010.	  Using	  estimates	  from	  these	  data,	  as	  well	  as	  from	  the	  literature,	  a	  pair	  of	  compartmental	  transmission	  models,	  one	  deterministic	  and	  the	  other	  stochastic,	  
	   iv	  
were	  created	  to	  evaluate	  the	  potential	  effect	  of	  the	  use	  of	  fecal	  transplantation	  as	  a	  treatment	  to	  prevent	  CDI.	  
	   The	  analysis	  of	  the	  cohort	  of	  incident	  cases	  suggested	  that	  ICU	  patients	  experience	  a	  greater	  burden	  of	  mortality	  while	  infected	  with	  C.	  difficile	  and	  have	  longer	  lengths	  of	  stay	  and	  times	  until	  death,	  suggesting	  this	  population	  as	  one	  of	  special	  interest.	  Two	  interventions	  were	  simulated	  using	  the	  stochastic	  model:	  the	  use	  of	  fecal	  transplantation	  to	  treat	  CDI	  and	  prevent	  recurrent	  cases	  and	  the	  use	  of	  fecal	  transplantation	  after	  treatment	  with	  antibiotics	  or	  PPIs	  to	  prevent	  the	  development	  of	  CDI.	  Simulation	  results	  showed	  that	  treating	  patients	  with	  CDI	  was	  effective	  in	  preventing	  recurrence	  but	  not	  in	  reducing	  the	  overall	  number	  of	  incident	  cases	  of	  CDI.	  Transplantation	  after	  treatment	  with	  antibiotics	  or	  PPIs	  had	  no	  effect	  on	  preventing	  recurrence	  and	  a	  statistically	  significant	  reduction	  in	  incident	  cases	  that	  did	  not	  reach	  clinical	  significance.	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  Chapter	  1:	  Background	  and	  Specific	  Aims	  	  
	   Clostridium	  difficile	  is	  a	  frequent	  source	  of	  healthcare-­‐associated	  infection	  (HAI),	  especially	  among	  patients	  on	  prolonged	  antibiotic	  treatment	  regimens	  or	  other	  conditions	  involving	  the	  disruption	  of	  normal	  gut	  flora.	  C.	  difficile	  is	  the	  most	  commonly	  recognized	  etiological	  agent	  for	  healthcare-­‐associated	  diarrhea,	  and	  consequences	  of	  infection	  range	  from	  uncomplicated	  diarrhea	  to	  colitis	  and	  death.	  	  
C.	  difficile	  infection	  (CDI)	  is	  also	  a	  problem	  of	  growing	  importance.	  The	  appearance	  and	  spread	  of	  a	  relatively	  rare	  strain	  identified	  as	  group	  BI	  by	  restriction	  endonuclease	  analysis,	  ribotype	  027	  by	  polymerase	  chain	  reaction,	  and	  North	  American	  pulse-­‐field	  gel	  electrophoresis	  type	  1	  –	  often	  abbreviated	  as	  BI/NAP1/027	  in	  Canada	  and	  soon	  after	  the	  U.S.	  and	  Europe,	  beginning	  in	  2000	  has	  been	  associated	  with	  a	  marked	  increase	  in	  CDI	  cases	  in	  these	  areas.	  The	  BI/NAP1/027	  strain	  is	  characterized	  by	  a	  high	  mortality	  rate,	  which	  may	  be	  the	  result	  of	  increased	  virulence,	  increased	  antibiotic	  resistance,	  or	  both1-­‐3.	  
	   Rates	  of	  CDI-­‐related	  hospitalizations	  and	  fatalities	  have	  been	  steadily	  rising	  (Figure	  1-­‐1).	  In	  a	  recent	  report4,	  CDI	  eclipsed	  methicillin-­‐resistant	  Staphylococcus	  
aureus	  (MRSA)	  as	  the	  leading	  source	  of	  HAIs	  within	  the	  Duke	  Infection	  Control	  Outreach	  Network	  (DICON)	  group	  of	  hospitals.	  While	  a	  later	  study	  from	  the	  same	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group	  of	  hospitals	  (Moehring	  et	  al,	  unpublished)	  found	  no	  evidence	  of	  a	  continued	  increase	  in	  the	  2009	  to	  2010	  period,	  infection	  rates	  remain	  elevated.	  
Beyond	  the	  burden	  of	  morbidity	  and	  mortality,	  CDI	  represents	  a	  significant	  drain	  on	  the	  healthcare	  resources	  of	  the	  United	  States	  and	  abroad.	  In	  2009,	  there	  were	  an	  estimated	  336,565	  cases	  in	  the	  United	  States	  based	  on	  discharge	  data	  from	  the	  Nationwide	  Inpatient	  Sample	  (NIS)	  from	  the	  Healthcare	  Cost	  and	  Utilization	  Project	  (HCUP),	  Agency	  for	  Healthcare	  Research	  and	  Quality.	  Recent	  estimates	  place	  the	  cost	  of	  a	  single	  C.	  difficile	  infection	  at	  $2,000	  per	  case	  for	  mild	  and	  uncomplicated	  cases	  to	  upwards	  of	  $90,000	  in	  the	  most	  severe	  cases5,6,	  with	  an	  estimated	  total	  burden	  on	  the	  U.S.	  healthcare	  system	  of	  over	  $500,000,000.	  	  
	   Many	  problems	  in	  hospital	  infection	  control	  are	  difficult	  to	  study	  empirically,	  for	  both	  practical	  and	  methodological	  reasons.	  As	  the	  purpose	  of	  a	  hospital	  is	  to	  treat,	  rather	  than	  study,	  patients,	  interventions	  to	  halt	  the	  spread	  of	  an	  infection	  are	  not	  done	  in	  a	  stepwise	  fashion,	  trying	  each	  potential	  intervention	  in	  turn.	  Instead,	  they	  are	  often	  deployed	  as	  a	  “bundle”	  of	  interventions,	  and	  once	  the	  spread	  of	  infection	  has	  been	  eliminated	  or	  lessened,	  we	  are	  left	  only	  with	  knowing	  that	  some	  component	  or	  components	  of	  that	  bundle	  were	  successful.	  
	   Compounding	  this	  practical	  problem	  are	  two	  serious	  violations	  of	  normal	  statistical	  assumptions,	  and	  as	  such	  conventional	  observational	  methods.	  First,	  patients	  cannot	  be	  considered	  statistically	  independent	  from	  one	  another.	  They	  are	  correlated	  by	  a	  number	  of	  factors,	  including	  the	  staff	  they	  are	  treated	  by,	  the	  ward	  and	  even	  hospital	  they	  are	  in.	  Second,	  the	  exposure	  status	  of	  one	  patient	  is	  not	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independent	  of	  the	  disease	  status	  of	  another	  –	  indeed	  an	  infected	  patient	  acts	  as	  the	  source	  of	  exposure	  for	  a	  currently	  uninfected	  patient	  (dependent	  happenings).	  	  
	   These	  problems	  may	  be	  addressed	  with	  the	  use	  of	  mathematical	  models,	  which	  model	  the	  theoretical	  process	  by	  which	  infection	  is	  translated	  from	  one	  patient	  to	  another.	  These	  serve	  as	  virtual,	  quantitative	  environments	  within	  which	  controlled,	  repeatable	  experiments	  can	  be	  conducted.	  However,	  these	  models	  are	  not	  without	  their	  own	  assumptions.	  This	  dissertation	  seeks	  to	  compose	  a	  rigorous	  mathematical	  model	  of	  C.	  difficile	  transmission	  within	  a	  healthcare	  setting	  and	  provide	  a	  systematic	  evaluation	  of	  some	  of	  those	  assumptions	  within	  the	  context	  of	  hospital	  infection	  control.	  	  
Aim	  1:	  The	  elucidation	  of	  the	  parameter	  estimates	  governing	  models	  of	  C.	  
difficile	  transmission.	  	  
Aim	  1a:	  Estimation	  of	  incidence,	  time	  until	  death	  and	  time	  until	  discharge	  from	  cohort	  and	  surveillance	  time-­‐series	  data	  obtained	  from	  the	  Duke	  Infection	  Control	  Outreach	  Network	  (DICON).	  
Aim	  1b:	  Estimation	  of	  non-­‐CDI	  specific	  parameters,	  such	  as	  the	  overall	  time	  until	  discharge,	  proportion	  of	  admissions	  with	  active	  CDI	  and	  exposure	  to	  CDI-­‐risk	  factors	  such	  as	  proton	  pump	  inhibitors	  (PPIs)	  and	  fluoroquinolones	  from	  administrative	  data	  obtained	  from	  the	  Carolina	  Data	  Warehouse	  for	  Health.	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Rationale:	  In	  order	  to	  comprehensively	  compare	  different	  model	  types,	  a	  set	  of	  validly	  estimated	  parameters	  that	  will	  be	  used	  throughout	  the	  analysis	  must	  first	  be	  obtained.	  This	  aim	  provides	  as	  many	  parameter	  estimates	  as	  possible	  using	  modern	  epidemiological	  methods.	  
Aim	  2:	  Comparison	  of	  parameter	  estimation	  methods	  and	  sources	  of	  between-­‐	  
and	  within-­‐model	  sources	  of	  uncertainty.	  	  
Aim	  2a.	  Comparison	  of	  the	  estimates	  obtained	  from	  fitting	  a	  deterministic	  compartmental	  model	  to	  an	  incidence	  time	  series	  to	  an	  approach	  directly	  linking	  an	  incidence	  estimate	  from	  a	  regression	  model	  to	  the	  corresponding	  parameter	  within	  the	  mathematical	  model.	  
Aim	  2b.	  Comparing	  the	  results	  of	  a	  deterministic	  compartmental	  model	  with	  the	  parameters	  obtained	  in	  Aims	  1	  and	  2a	  to	  an	  identically	  parameterized	  stochastic	  compartmental	  model.	  
Rationale:	  Traditionally,	  the	  estimation	  of	  transmission	  parameters	  is	  done	  from	  within	  a	  mathematical	  model	  itself,	  fitting	  a	  parameter	  or	  group	  of	  parameters	  using	  a	  method	  such	  as	  least-­‐squares	  or	  maximum	  likelihood.	  However,	  it	  is	  possible,	  at	  least	  in	  principle,	  to	  “back	  in”	  to	  a	  model	  parameter	  directly	  from	  incidence	  estimates.	  This	  aim	  seeks	  to	  compare	  these	  two	  techniques,	  and	  evaluate	  the	  possibility	  of	  leveraging	  multiple	  incidence	  estimates	  from	  a	  number	  of	  sites,	  studies,	  meta-­‐analyses	  etc.	  to	  provide	  a	  more	  robust	  parameter	  estimate.	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This	  aim	  also	  seeks	  to	  explore	  issues	  around	  parameter	  uncertainty.	  In	  order	  for	  a	  deterministic	  model	  fit	  to	  a	  time	  series	  to	  be	  an	  appropriate	  representation	  of	  a	  stochastic	  process,	  the	  deterministic	  results	  themselves	  must	  be	  a	  good	  approximation	  of	  the	  most	  common	  outcomes	  of	  the	  stochastic	  process.	  By	  fitting	  an	  identically	  parameterized	  stochastic	  model,	  we	  may	  evaluate	  how	  well	  this	  assumption	  holds.	  
Aim	  3:	  Application	  of	  dynamic	  transmission	  models	  to	  hospital	  infection	  
control	  practice,	  assessing	  the	  impact	  of	  colonized/active	  CDI	  cases	  admitted	  
from	  the	  community,	  hand	  washing	  compliance	  and	  other	  variables	  of	  interest	  
to	  infection	  control	  on	  the	  modeled	  transmission	  of	  C.	  difficile.	  
Rationale:	  While	  Aim	  1	  and	  2	  seek	  to	  establish	  a	  robust	  model	  of	  C.	  difficile	  transmission	  with	  carefully	  considered	  assumptions,	  the	  purpose	  of	  Aim	  3	  is	  to	  apply	  this	  model	  to	  public	  health	  practice.	  Several	  major	  questions	  in	  infection	  control,	  such	  as	  to	  what	  extent	  approaching	  100%	  hand	  hygiene	  compliance	  might	  effect	  transmission	  within	  the	  hospital,	  what	  role	  asymptomatic	  carriers	  of	  C.	  
difficile	  play	  in	  transmission,	  etc.	  can	  be	  addressed	  using	  this	  model,	  providing	  possible	  mechanistic	  explanations	  for	  findings	  from	  observational	  studies	  or	  suggesting	  new	  directions	  for	  inquiry.	  	  











Figure	  1-­‐1.	  Discharge	  rate	  for	  C.	  difficile-­‐associated	  disease	  per	  1,000	  hospital	  discharges,	  1997-­‐2009.	  Data	  from	  weighted	  national	  estimates	  from	  HCUP	  Nationwide	  Inpatient	  Sample	  (NIS).






























Chapter	  2:	  The	  Use	  of	  Mathematical	  Models	  to	  Study	  
Healthcare-­‐associated	  Infection	  	  
	   Hospitals	  are	  inherently	  difficult	  settings	  in	  which	  to	  conduct	  observational	  research,	  which	  complicates	  the	  study	  of	  healthcare-­‐associated	  infections.	  Because	  patients	  are	  treated	  by	  the	  same	  set	  of	  doctors,	  nurses	  and	  other	  healthcare	  personnel	  (HCP)	  and	  share	  the	  same	  environment,	  the	  assumption	  of	  independence	  between	  patients	  that	  underlies	  many	  traditional	  statistical	  methods	  is	  questionable.	  Healthcare-­‐associated	  infections	  are	  also	  a	  clear	  case	  of	  the	  problem	  of	  “dependent	  happenings”	  –	  when	  the	  exposure	  status	  of	  one	  individual	  is	  dependent	  on	  the	  disease	  status	  of	  those	  around	  them.	  Patients	  with	  HAIs	  shed	  infectious	  material	  into	  the	  environment,	  contaminate	  HCP	  hands,	  and	  transmit	  infections	  directly	  as	  they	  come	  into	  contact	  with	  other	  patients.	  Finally,	  as	  research	  is	  of	  secondary	  concern	  when	  compared	  to	  patient	  care,	  much	  of	  the	  observational	  research	  that	  is	  done	  is	  based	  on	  examining	  a	  “bundle”	  7	  or	  collection	  of	  interventions	  all	  tried	  simultaneously	  to	  arrest	  an	  epidemic	  within	  a	  hospital.	  While	  useful,	  these	  studies	  can	  only	  demonstrate	  that	  one	  or	  more	  components	  of	  the	  bundle	  were	  successful,	  not	  highlight	  the	  role	  of	  any	  one	  intervention.	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   Mathematical	  models	  are	  ideal	  for	  addressing	  these	  challenges.	  Designed	  to	  capture	  the	  dynamics	  of	  a	  system	  –	  like	  a	  hospital	  –	  as	  a	  whole,	  they	  are	  unburdened	  by	  assumptions	  of	  independence	  between	  patients	  by	  explicitly	  modeling	  how	  patients	  interact	  with	  one	  another.	  In	  doing	  so,	  they	  extend	  the	  empirical	  evidence	  we	  do	  have	  from	  observations	  based	  on	  individuals	  to	  ask	  research	  questions	  about	  the	  system	  as	  a	  whole.	  Mathematical	  models	  also	  provide	  a	  means	  to	  examine	  a	  system	  under	  the	  effects	  of	  multiple	  interventions,	  such	  as	  a	  hospital	  using	  a	  prevention	  bundle,	  and	  evaluate	  the	  effect	  of	  each	  intervention	  in	  turn8,	  or	  in	  combination,	  in	  a	  repeatable,	  quantitative	  environment.	  
Model	  Structure	  and	  Composition	  
	   Mathematical	  models,	  at	  their	  core,	  are	  an	  attempt	  to	  quantitatively	  describe	  the	  way	  in	  which	  a	  system	  under	  study	  –	  such	  as	  the	  transmission	  of	  disease	  within	  a	  hospital	  –	  works.	  For	  any	  one	  research	  question,	  there	  are	  potentially	  infinite	  ways	  to	  describe	  a	  system	  with	  varying	  levels	  of	  complexity,	  different	  sets	  of	  assumptions,	  and	  exploring	  different	  facets	  of	  the	  underlying	  processes	  that	  drive	  what	  we	  observe	  in	  the	  real	  world.	  A	  few	  commonly	  used	  types	  of	  models	  are	  discussed	  below.	  	  
Deterministic	  Compartmental	  Models	  
	   Deterministic	  compartmental	  models	  are	  by	  far	  the	  most	  commonly	  used	  models	  in	  mathematical	  epidemiology	  today.	  Patients	  are	  grouped	  into	  a	  series	  of	  health	  states	  known	  as	  compartments	  with	  the	  rates	  that	  govern	  the	  transition	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  (Eq.	  1)	  
These	  types	  of	  models	  have	  been	  extensively	  used	  in	  the	  epidemiological	  literature	  since	  the	  work	  of	  Kermack	  and	  McKendrick9,	  though	  they	  were	  more	  recently	  popularized	  by	  Anderson	  and	  May10,11.	  
	   The	  use	  of	  these	  models	  in	  the	  study	  of	  HAIs	  is	  somewhat	  more	  recent,	  reflecting	  the	  emergence	  of	  pathogens	  such	  as	  MRSA	  and	  C.	  difficile	  as	  major	  threats	  to	  public	  health	  (e.g.	  12-­‐14).	  Most	  are	  single-­‐ward	  adaptations	  of	  the	  Ross-­‐Macdonald	  model,	  a	  model	  originally	  developed	  for	  malaria	  control	  research15.	  These	  models	  assume	  that	  disease	  acquisition	  is	  the	  result	  of	  indirect	  interaction	  with	  HCP	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“vectors”	  carrying	  infection	  from	  an	  infected	  patient	  to	  a	  susceptible	  patient	  (Figure	  2-­‐1).	  
	   In	  their	  most	  basic	  form,	  these	  models	  represent	  both	  the	  HCP	  and	  patient	  populations	  as	  two	  compartments	  –	  one	  for	  members	  of	  each	  group	  who	  are	  not	  yet	  colonized	  or	  contaminated	  (depending	  on	  which	  pathogen	  is	  being	  modeled)	  and	  one	  for	  those	  who	  are.	  Transmission	  occurs	  when	  a	  contaminated/colonized	  member	  of	  one	  group	  comes	  into	  contact	  with	  an	  uncontaminated/colonized	  member	  of	  the	  other	  group.	  The	  reasons	  for	  using	  this	  particular	  form	  are	  myriad.	  The	  analogy	  between	  HCPs	  and	  vectors	  is	  intuitive	  and	  easy	  to	  understand,	  the	  model	  –	  and	  extensions	  of	  it	  –	  have	  proven	  remarkable	  flexible	  in	  describing	  a	  variety	  of	  disease	  systems,	  and	  the	  equations	  that	  make	  up	  the	  Ross-­‐Macdonald	  model	  are	  extensively	  studied	  and	  analytically	  tractable,	  allowing	  for	  results	  based	  purely	  on	  the	  mathematical	  properties	  of	  the	  system,	  rather	  than	  on	  any	  particular	  combination	  of	  parameter	  values.	  	  
	   These	  models	  do,	  however,	  have	  several	  major	  assumptions	  and	  limitations	  inherent	  to	  them	  that	  may	  threaten	  their	  validity.	  First,	  they	  assume	  uniform,	  random	  contact	  between	  compartments	  that	  interact	  with	  one	  another	  –	  for	  example,	  that	  all	  HCPs	  see	  all	  patients.	  While	  it	  is	  possible	  to	  segment	  the	  population	  into	  more	  and	  more	  refined	  compartments	  to	  address	  this	  assumption	  (e.g.	  splitting	  HCP	  compartments	  into	  compartments	  for	  nurses,	  residents,	  medical	  students,	  technicians,	  etc.),	  this	  is	  extremely	  cumbersome	  mathematically	  after	  a	  small	  number	  of	  such	  divisions,	  and	  the	  assumption	  remains	  true	  within	  a	  given	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interaction	  between	  two	  compartments.	  Extending	  the	  example	  used	  previously,	  even	  if	  medical	  students	  only	  see	  a	  particular	  group	  of	  patients,	  the	  contact	  between	  them	  is	  uniform	  and	  random.	  Second,	  these	  models	  assume	  strictly	  patient-­‐to-­‐HCP-­‐to-­‐patient	  transmission,	  without	  a	  role	  for	  indirect	  transmission	  through	  the	  environment,	  which	  may	  play	  a	  substantial	  role	  in	  the	  transmission	  of	  many	  healthcare-­‐associated	  infections16.	  Third,	  these	  models	  are	  memory-­‐less	  –	  they	  do	  not	  follow	  the	  course	  of	  individual	  patients	  moving	  through	  the	  model,	  but	  rather	  model	  the	  behavior	  of	  the	  population	  within	  each	  compartment	  as	  a	  group.	  This	  means	  that	  while	  you	  can	  track	  outcomes	  such	  as	  how	  many	  infections	  occur,	  how	  many	  HCPs	  have	  transient	  hand	  contamination,	  etc.	  you	  cannot	  say	  which	  individuals	  have	  these	  outcomes.	  Beyond	  this,	  these	  types	  of	  models	  allow	  for	  non-­‐integer	  numbers	  of	  individuals	  in	  each	  compartment;	  it	  is	  perfectly	  possible	  to	  have	  0.20	  infected	  patients,	  regardless	  of	  the	  biological	  plausibility	  of	  such	  a	  scenario.	  Finally,	  these	  models	  are	  purely	  deterministic	  –	  there	  is	  no	  mechanism	  to	  account	  for	  probability	  and	  randomness	  within	  the	  system.	  While	  in	  large	  populations	  these	  deterministic	  results	  might	  be	  considered	  the	  “average”	  outcome	  of	  the	  underlying	  stochastic	  reality	  of	  the	  real	  world,	  for	  small	  populations	  this	  assumption	  is	  problematic,	  making	  deterministic	  models	  frequently	  inappropriate	  for	  use	  in	  settings	  like	  the	  modeling	  of	  infection	  transmission	  within	  a	  single	  ward	  or	  hospital.	  
Stochastic	  Compartmental	  Models	  
	   Adopting	  the	  same	  compartmental	  framework,	  but	  allowing	  for	  the	  effects	  of	  randomness	  is	  a	  logical	  and	  relatively	  straightforward	  extension	  of	  the	  deterministic	  
	   12	  
compartmental	  model.	  There	  are	  a	  number	  of	  ways	  to	  accomplish	  this.	  Perhaps	  the	  most	  accessable	  is	  the	  use	  of	  an	  “event-­‐driven	  approach”.	  Instead	  of	  modeling	  the	  movement	  of	  the	  population	  between	  compartments	  at	  very	  small	  time	  increments,	  as	  the	  deterministic	  model	  does,	  this	  approach	  instead	  uses	  the	  same	  baseline	  rates	  as	  the	  deterministic	  model	  to	  probabilistically	  generate	  a	  list	  of	  events	  and	  when	  they	  occur,	  adjusting	  the	  numbers	  in	  each	  compartment	  accordingly.	  For	  example,	  this	  approach	  might	  determine	  that	  at	  time	  t	  =	  5,	  a	  susceptible	  patient	  is	  infected.	  Thus,	  when	  the	  simulation	  reaches	  t	  =	  5,	  the	  population	  of	  the	  susceptible	  compartment	  is	  reduced	  by	  one,	  and	  the	  infected	  compartment	  increased	  by	  one.	  This	  approach	  has	  the	  two-­‐fold	  advantage	  of	  incorporating	  randomness	  in	  the	  system	  and	  forcing	  compartment	  populations	  to	  be	  integer-­‐valued,	  better	  reflecting	  the	  nature	  of	  reality17.	  One	  well-­‐known	  algorithm	  for	  implementing	  such	  a	  stochastic	  model	  is	  Gillespie’s	  Direct	  Method18.	  This	  method	  works	  by	  calculating	  the	  time	  until	  the	  next	  event	  based	  on	  the	  cumulative	  rates	  of	  all	  possible	  events	  in	  the	  model,	  converting	  each	  of	  these	  rates	  into	  probabilities,	  and	  then	  randomly	  selecting	  one	  of	  these	  possibilities	  using	  a	  random	  number	  generator.	  This	  process	  is	  then	  repeated	  through	  time	  until	  the	  simulation	  comes	  to	  an	  end.	  
	   The	  use	  of	  such	  a	  stochastic	  approach	  has	  several	  key	  features.	  In	  small	  populations,	  random	  fluctuations	  may	  play	  an	  important	  role	  –	  for	  example,	  while	  a	  deterministic	  model	  may	  predict	  0.20	  infected	  patients,	  a	  stochastic	  model	  must	  express	  the	  infected	  patient	  population	  as	  either	  one	  or	  zero,	  and	  if	  that	  number	  is	  zero,	  infection	  transmission	  becomes	  impossible.	  This	  process	  is	  known	  as	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stochastic	  extinction,	  and	  it	  plays	  a	  major	  role	  in	  the	  dynamics	  of	  infection	  within	  small	  populations.	  However,	  purely	  mathematical	  analysis	  of	  the	  system	  becomes	  somewhat	  more	  difficult.	  As	  a	  single	  simulation	  of	  the	  system	  represents	  only	  one	  potential	  probabilistic	  outcome	  out	  of	  many,	  it	  is	  necessary	  to	  run	  many	  simulations	  of	  the	  same	  model.	  This	  increases	  the	  amount	  of	  computation	  time	  necessary	  to	  obtain	  results	  and	  necessitates	  statistical	  analysis	  to	  analyze	  results	  rather	  than	  being	  able	  to	  rely	  purely	  on	  mathematical	  results.	  Additionally,	  while	  stochastic	  compartmental	  models	  address	  some	  of	  the	  assumptions	  behind	  their	  deterministic	  cousins,	  they	  share	  the	  assumption	  of	  random	  mixing	  between	  compartments,	  and	  transmission	  from	  person-­‐to-­‐person	  (or	  patient-­‐to-­‐HCP-­‐to-­‐patient	  in	  the	  case	  of	  healthcare-­‐associated	  infections).	  
Network	  and	  Agent-­‐based	  Models	  
	   Addressing	  the	  assumptions	  shared	  by	  both	  forms	  of	  compartmental	  model	  requires	  the	  adoption	  of	  considerably	  more	  computationally	  sophisticated	  models.	  As	  these	  models	  are	  not	  the	  focus	  of	  this	  dissertation,	  they	  will	  be	  discussed	  only	  briefly.	  
	   Network	  models	  explicitly	  model	  individuals	  and	  the	  interactions	  between	  them,	  lifting	  the	  assumption	  of	  random	  mixing.	  Individuals	  within	  the	  model	  	  have	  specific	  health	  states	  very	  similar	  to	  those	  in	  compartment-­‐based	  models	  –	  susceptible,	  infected,	  etc.	  Disease	  transmission	  takes	  place	  not	  through	  the	  random	  encounters	  between	  infected	  and	  susceptible	  individuals,	  but	  across	  the	  links	  between	  them.	  These	  models	  have	  a	  number	  of	  strengths	  –	  they	  are	  especially	  useful	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for	  examining	  research	  questions	  about	  how	  contact	  between	  individuals	  effects	  disease	  transmission.	  For	  example,	  the	  effect	  of	  individuals	  preferentially	  forming	  links	  based	  one	  who	  that	  person	  knows19	  or	  the	  impact	  of	  dividing	  HCP	  into	  teams	  that	  see	  only	  specific	  patients	  or	  other	  cohorting	  strategies20.	  Unlike	  compartmental	  models,	  they	  are	  not	  “memory-­‐less”	  –	  they	  can,	  and	  indeed	  must,	  model	  individual	  patients	  as	  unique	  entities.	  This	  allows	  for	  the	  potential	  to	  include	  patient	  covariates	  such	  as	  age,	  race	  or	  gender	  to	  modify	  their	  disease	  risk,	  and	  modeling	  individuals	  allows	  for	  the	  analysis	  of	  the	  population	  in	  a	  way	  that	  is	  directly	  analogous	  to	  a	  real-­‐world	  population,	  allowing	  them	  to	  be	  analyzed	  and	  interpreted	  as	  virtual	  cohorts	  
21.	  This	  individual-­‐level	  modeling	  also	  allows	  for	  the	  introduction	  of	  sophisticated	  forms	  of	  stochasticity,	  such	  as	  alterations	  in	  mixing	  patterns,	  and	  parameters	  arising	  from	  complex	  probability	  distributions	  that	  elude	  compartmental	  models.	  
	   These	  strengths	  do	  however	  have	  drawbacks.	  The	  mathematics	  behind	  the	  dynamics	  of	  infection	  across	  a	  network	  are	  complex,	  usually	  necessitating	  simulation-­‐based	  implementations	  that,	  compared	  to	  compartmental	  models,	  are	  more	  difficult	  to	  program	  and	  more	  computationally	  intensive.	  Beyond	  the	  complexity	  of	  their	  implementation,	  these	  models	  also	  have	  somewhat	  more	  burdensome	  data	  requirements.	  In	  addition	  to	  parameters	  detailing	  the	  natural	  history	  of	  the	  disease,	  researchers	  must	  also	  specify	  the	  contact	  patterns	  between	  individuals.	  Empirically	  obtained	  network	  data	  is	  relatively	  rare	  and	  difficult	  to	  collect22,	  and	  while	  artificially	  generated	  networks	  that	  follow	  certain	  empirically-­‐derived	  distributions	  (e.g.23)	  may	  be	  used	  in	  place	  of	  direct	  data,	  this	  only	  replaces	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the	  random	  mixing	  assumption	  of	  compartmental	  models	  with	  a	  more	  refined	  assumption	  about	  how	  individuals	  interact,	  rather	  than	  avoiding	  the	  assumption	  completely.	  Finally,	  these	  models	  generally	  are	  meant	  to	  model	  person-­‐to-­‐person	  transmission,	  though	  it	  is	  possible	  to	  model	  environmental	  transmission	  by	  the	  links	  between	  individuals	  representing	  shared	  contact	  with	  the	  same	  environment,	  rather	  than	  direct	  contact.	  However,	  this	  type	  of	  abstraction	  does	  not	  model	  the	  environment	  itself,	  only	  the	  shared	  use	  of	  it.	  
	   Perhaps	  the	  most	  flexible	  type	  of	  model	  is	  an	  agent-­‐based	  model,	  where	  individuals	  are	  modeled	  within	  an	  environment,	  with	  their	  behaviors	  and	  interactions	  governed	  by	  a	  set	  of	  rules.	  These	  rules	  can	  be	  extremely	  complex,	  based	  on	  the	  agent’s	  environment,	  current	  health	  status,	  the	  status	  of	  those	  around	  them,	  etc.	  (e.g.	  24),	  or	  quite	  simple.	  For	  example,	  rules	  allowing	  random	  mixing	  which	  allows	  agent-­‐based	  models	  to	  act	  as	  an	  individual-­‐based	  implementation	  of	  a	  compartmental	  model	  system.	  Agent-­‐based	  models	  share	  many	  of	  the	  same	  strengths	  with	  network-­‐models,	  arising	  from	  the	  representation	  of	  individuals	  within	  the	  model	  as	  discrete	  entities,	  while	  also	  allowing	  for	  the	  direct	  modeling	  of	  individuals	  within	  their	  environment,	  more	  complex	  behavioral	  patterns,	  etc.	  This	  flexibility	  comes	  at	  the	  cost	  of	  even	  higher	  computational	  complexity	  than	  network	  models	  and	  greater	  requirements	  for	  data	  from	  which	  to	  derive	  parameter	  values	  to	  describe	  an	  ever	  more	  complex	  system.	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Meta-­‐Population	  Models	  
	   Meta-­‐population	  models	  are	  extensions	  of	  the	  any	  of	  the	  models	  described	  above.	  A	  meta-­‐population	  model	  breaks	  up	  a	  larger	  population,	  such	  as	  an	  entire	  healthcare	  system	  (e.g.25,26)	  into	  individual	  hospitals	  and	  long	  term	  care	  facilities,	  or	  a	  single	  hospital	  into	  its	  constituent	  wards,	  modeling	  the	  movement	  of	  individuals	  both	  within	  the	  smaller	  sub-­‐models	  and	  between	  them.	  These	  types	  of	  models	  are	  best	  thought	  of	  as	  a	  collection	  of	  smaller	  models,	  with	  the	  corresponding	  assumptions,	  strengths	  and	  weaknesses	  that	  accompany	  them.	  
Modeling	  C.	  difficile	  Transmission	  
	   The	  current	  literature	  on	  the	  modeling	  of	  C.	  difficile	  is	  relatively	  sparse,	  even	  when	  compared	  to	  other	  HAIs	  such	  as	  MRSA,	  which	  has	  thus	  far	  dominated	  the	  mathematical	  modeling	  literature	  as	  concerns	  hospital	  infections	  (e.g.	  13,25-­‐30	  among	  others.	  A	  selection	  of	  the	  models	  that	  do	  exist	  is	  discussed	  below	  and	  summarized	  in	  Table	  2-­‐1.	  
Starr	  and	  colleagues	  argue	  in	  two	  separate	  papers31,32	  that	  a	  mathematical	  modeling	  approach	  is	  needed	  to	  understand	  the	  dynamics	  of	  C.	  difficile,	  citing	  the	  lack	  of	  independence	  between	  a	  given	  patient’s	  level	  of	  exposure	  and	  the	  number	  of	  infected	  patients	  present	  in	  a	  hospital.	  The	  earlier	  of	  the	  two	  papers31	  outlines	  a	  model	  of	  C.	  difficile	  transmission	  that	  is	  entirely	  patient	  centric,	  possessing	  five	  compartments	  to	  describe	  a	  patient’s	  health	  state:	  “Resistant,	  uncolonized”	  for	  patients	  who	  are	  uncolonized	  with	  the	  organism	  and	  who	  possess	  some	  resistance	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to	  colonization	  –	  for	  example	  patients	  with	  healthy	  gut	  flora,	  “Resistant,	  colonized”	  for	  patients	  who,	  despite	  having	  resistant	  traits	  have	  become	  colonized	  with	  C.	  
difficile,	  “Susceptible,	  uncolonized”	  for	  patients	  who,	  while	  not	  yet	  colonized	  are	  at	  elevated	  risk	  for	  such	  an	  event,	  “Susceptible,	  colonized”	  for	  those	  higher	  risk	  patients	  who	  have	  become	  colonized,	  and	  “Toxin-­‐positive	  diarrhea”	  for	  those	  who	  have	  developed	  clinically	  evident	  disease.	  This	  early	  paper	  does	  not	  however	  actually	  attempt	  to	  model	  the	  disease	  process	  itself	  –	  rather,	  it	  suggests	  using	  a	  mathematical	  modeling	  and	  population-­‐level	  approach	  more	  as	  a	  conceptual	  basis	  from	  which	  to	  consider	  infection	  control	  measures	  for	  C.	  difficile	  and	  recognizes	  that	  the	  effect	  of	  any	  intervention	  will	  depend	  on	  the	  context	  in	  which	  it	  is	  attempted.	  	  
The	  later	  paper32	  implements	  this	  model	  using	  a	  Markov	  Chain	  Monte	  Carlo-­‐based	  implementation	  in	  an	  attempt	  to	  capture	  both	  the	  stochasticity	  inherent	  to	  small-­‐population	  outbreaks	  and	  to	  draw	  inferences	  about	  so-­‐called	  “hidden	  states”	  within	  the	  model,	  notably	  patient	  health	  states	  that	  are	  not	  normally	  observed,	  such	  as	  pre-­‐clinical	  colonization	  status.	  The	  paper	  is	  notably	  lacking	  in	  mathematical	  detail,	  though	  the	  authors	  present	  an	  important	  result:	  environmental	  contamination	  alone	  is	  capable	  of	  driving	  small	  (	  <4	  patients)	  sporadic	  outbreaks,	  but	  the	  larger	  outbreaks	  seen	  in	  many	  hospital	  settings	  also	  require	  some	  person-­‐to-­‐person	  transmission	  process.	  It	  should	  be	  noted	  that	  the	  “environment”	  in	  this	  model	  appears	  to	  be	  modeled	  as	  a	  constant,	  fixed	  “infective	  pressure”	  on	  patients,	  and	  does	  not	  change	  based	  on	  the	  number	  of	  infected	  patients	  in	  the	  ward.	  Given	  that	  environmental	  contamination	  arises	  from	  patients	  shedding	  C.	  difficile	  into	  the	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environment,	  this	  assumption	  seems	  problematic.	  Additionally,	  there	  is	  no	  account	  for	  incoming	  prevalent	  infected	  or	  colonized	  cases	  from	  the	  community,	  which	  may	  play	  an	  important	  role	  in	  seeding	  wards	  that	  would	  otherwise	  be	  free	  of	  infection33.	  
	   A	  more	  recent	  model	  by	  Starr	  et	  al.34	  uses	  a	  similar	  approach	  with	  considerable	  more	  methodological	  detail	  examines	  a	  number	  of	  potential	  infection	  control	  strategies.	  Building	  off	  a	  390	  patient,	  two-­‐ward	  hospital	  data	  set,	  the	  authors	  find	  that	  interventions	  that	  influence	  patient	  susceptibility	  to	  C.	  difficile	  	  (i.e.	  antibiotic	  stewardship)	  are	  considerably	  more	  effective	  at	  reducing	  infection	  compared	  to	  environmental	  decontamination	  strategy	  or	  strategies	  that	  interrupt	  transmission.	  Again	  however,	  several	  caveats	  to	  this	  finding	  are	  needed.	  The	  environment	  is,	  again,	  modeled	  as	  a	  constant	  background	  colonization	  pressure,	  rather	  than	  a	  dynamic	  source	  of	  transmission	  that	  varies	  with	  the	  number	  of	  sick	  patients	  within	  the	  ward.	  Finally,	  despite	  having	  different	  patient	  compartments	  for	  patients	  not	  on	  antibiotics	  and	  on	  antibiotics,	  the	  MCMC	  algorithm	  estimated	  an	  essentially	  identical	  posterior	  transition	  rate	  from	  immune	  to	  susceptible	  to	  C.	  
difficile	  (0.012	  (95%	  Credible	  Interval:	  0.00081,	  0.01670)	  for	  patients	  not	  on	  antibiotics	  and	  0.013	  (95%	  CI:	  0.0078,	  0.020)	  for	  patients	  on	  antibiotics),	  and	  from	  there	  models	  these	  patients	  as	  identical.	  These	  findings	  are	  contrary	  to	  the	  generally	  accepted	  clinical	  evidence	  that	  antibiotic	  exposure	  puts	  one	  at	  increased	  risk	  for	  developing	  C.	  difficile35.	  
	   Grima	  et	  al.36	  examine	  the	  use	  of	  non-­‐antibiotic	  treatments	  for	  C.	  difficile,	  such	  as	  fecal	  transplant	  or	  currently-­‐unsuccessful	  use	  of	  tolevamer	  as	  a	  substitute	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for	  therapy	  with	  vancomycin	  or	  other	  antibiotics.	  However,	  the	  focus	  of	  their	  model	  is	  not	  C.	  difficile,	  but	  rather	  on	  the	  impact	  a	  reduction	  in	  the	  number	  of	  antibiotics	  used	  to	  treat	  the	  disease	  would	  have	  on	  the	  prevalence	  of	  other	  antibiotic	  resistant	  organisms,	  such	  as	  vancomycin-­‐resistant	  enterococci	  (VRE).	  The	  authors	  find	  that	  a	  decrease	  in	  antibiotics	  for	  the	  treatment	  of	  C.	  difficile	  results	  in	  a	  lower	  rate	  of	  subsequent	  colonization	  with	  VRE.	  The	  model	  however	  has	  some	  serious	  shortcomings.	  The	  model	  is	  deterministic,	  which	  makes	  it	  difficult	  to	  distinguish	  if	  the	  differences	  between	  model	  scenarios	  would	  manifest	  in	  a	  noticeably	  different	  clinical	  experience.	  Beyond	  this,	  the	  model	  assumes	  that	  neither	  VRE	  nor	  C.	  difficile	  can	  be	  acquired	  in	  patients	  not	  on	  antibiotics,	  thus	  positing	  that	  the	  use	  of	  non-­‐antibiotic	  treatments	  for	  C.	  difficile	  completely	  interrupt	  transmission	  in	  all	  circumstances	  –	  an	  extremely	  strong	  assumption.	  Finally,	  because	  the	  model	  is	  focused	  on	  VRE,	  clinically	  relevant	  outcomes	  for	  CDI	  patients,	  such	  as	  recurrence,	  are	  ignored.	  
	   Finally,	  a	  model	  of	  C.	  difficile	  transmission	  in	  a	  hospital	  by	  Lanzas	  et	  al37	  represents	  a	  model	  closest	  in	  form	  to	  the	  compartmental	  models	  detailed	  in	  later	  chapters.	  The	  model	  treats	  patients	  as	  being	  in	  one	  of	  five	  states	  –	  resistant	  (not	  at	  risk	  of	  C.	  difficile	  colonization),	  susceptible	  (susceptible	  to	  colonization	  having	  been	  treated	  with	  antibiotics),	  asymptomatically	  colonized	  with	  protection	  (colonized,	  but	  not	  progressing	  to	  CDI),	  asymptomatically	  colonized	  without	  protection	  (colonized	  and	  progressing	  to	  CDI)	  and	  diseased.	  The	  actual	  transmission	  is	  abstracted	  away,	  making	  the	  modeling	  of	  HCP-­‐oriented	  interventions	  difficult	  to	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implement.	  Building	  from	  parameter	  estimates	  in	  the	  literature	  and	  a	  hospital-­‐level	  data	  set,	  and	  using	  both	  deterministic	  and	  stochastic	  implementations	  of	  the	  model,	  the	  authors	  explore	  which	  parameters	  are	  influential	  in	  determining	  the	  basic	  reproductive	  number	  (R0)	  for	  the	  model	  –	  a	  measure	  of	  how	  many	  secondary	  infections	  will	  arise	  from	  a	  single	  primary	  infection	  and	  other	  measures	  of	  influence	  parameter	  values	  have	  on	  model	  outcomes.	  They	  found,	  in	  contrast	  to	  Starr	  et	  al.34,	  that	  parameters	  governing	  transmission	  had	  a	  much	  greater	  impact	  on	  overall	  rates	  of	  colonization	  and	  disease	  compared	  to	  those	  governing	  susceptibility.	  The	  authors	  suggest	  this	  may	  have	  been	  because	  the	  widespread	  use	  of	  antibiotics	  in	  the	  model	  eliminated	  the	  progression	  from	  resistant	  to	  susceptible	  as	  a	  meaningful	  rate-­‐limiting	  step	  in	  the	  transmission	  process.	  
Further	  Directions	  
	   The	  mathematical	  modeling	  landscape	  for	  C.	  difficile	  is	  relatively	  undeveloped,	  despite	  the	  disease’s	  considerable	  burden	  on	  the	  healthcare	  system.	  There	  have	  been	  few	  if	  any	  attempts	  to	  actively	  model	  clinical	  interventions.	  Rather,	  current	  models	  have	  predominantly	  sought	  to	  describe	  the	  infection	  process	  mathematically	  and	  quantify	  which	  parameters	  most	  influence	  the	  model	  –	  a	  useful	  process	  to	  identify	  targets	  for	  intervention,	  but	  one	  step	  removed	  from	  actual	  clinical	  impact.	  Despite	  growing	  evidence	  for	  the	  role	  surface	  contamination	  plays	  in	  the	  transmission	  of	  C.	  difficile16,38,39,	  little	  modeling	  has	  been	  done	  focusing	  on	  the	  role	  of	  the	  environment.	  Those	  models	  that	  do	  consider	  the	  role	  of	  environmental	  contamination	  abstract	  it	  to	  be	  a	  constant	  background	  colonization	  risk	  –	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understandable	  given	  the	  difficult	  compartmental	  models	  have	  in	  directly	  modeling	  environmental	  contamination.	  This	  abstraction	  does	  however	  ignore	  the	  fact	  that	  that,	  just	  as	  in	  person-­‐to-­‐person	  transmission,	  environmentally	  mediated	  transmission	  is	  a	  dynamic	  process.	  A	  patient’s	  exposure	  to	  environmental	  sources	  of	  transmission	  is	  a	  function	  of	  the	  number	  of	  other	  infected	  patients	  proximate	  to	  the	  patient	  in	  both	  space	  and	  time,	  rather	  than	  a	  constant	  background	  exposure.	  These	  types	  of	  models	  will	  be	  necessary	  in	  the	  future	  to	  both	  fully	  model	  the	  role	  of	  the	  environment	  in	  the	  transmission	  of	  C.	  difficile	  and	  to	  model	  interventions	  on	  the	  environment	  itself,	  such	  as	  disinfection	  and	  cleaning.	  
	  
Figure	  2-­‐1.	  Flow	  diagram	  for	  Ross-­‐Macdonald-­‐style	  healthcare-­‐associated	  infection	  model.	  Healthcare	  personnel	  are	  denoted	  as	  either	  uncolonized/contaminated	  (Us)	  or	  colonized/contaminated	  (H).	  Similarly,	  patients	  are	  shown	  as	  either	  uncolonized/contaminated	  (Up)	  or	  colonized/contaminated	  (Cp).	  Solid	  arrows	  indicate	  available	  paths	  to	  move	  between	  compartments,	  while	  dashed	  arrows	  indicate	  pathways	  of	  disease	  transmission.	  	  
H"Us"
UP" CP"
	   22	  
	  
Table	  2-­‐1.	  Key	  Mathematical	  Modeling	  Papers	  Focusing	  on	  Healthcare-­‐Associated	  
Clostridium	  difficile	  Transmission.	  Author	  (Year)	   Journal	   Model	  Type	   Key	  Findings	  Starr	  et	  al.	  (1997)	  	   Lancet	   Compartmental	   None	  (Conceptual	  framework).	  Starr	  et	  al.	  (2001)	   Clinical	  Microbiology	  and	  Infection	   Compartmental	  (Stochastic	  -­‐MCMC)	   Different	  outbreak	  signatures	  are	  obtained	  for	  different	  types	  of	  transmission	  (environmental,	  person-­‐to-­‐person,	  etc.).	  Starr	  et	  al.	  (2008)	   Journal	  of	  Hospital	  Infection	   Compartmental	  (Stochastic	  -­‐MCMC)	   Patient	  susceptibility	  is	  more	  important	  for	  infection	  than	  transmission	  rates.	  Lanzas	  et	  
al.	  (2011)	   Infection	  Control	  and	  Hospital	  Epidemiology	   Compartmental	  (Deterministic	  and	  Stochastic	  –	  Gillespie)	   Transmission	  rates	  dominate	  infection	  process;	  patient	  susceptibility	  parameters	  play	  a	  relatively	  minor	  role.	  Grima	  et	  
al.	  (2012)	   Computational	  and	  Mathematical	  Methods	  in	  Medicine	   Compartmental	  (Deterministic)	   Use	  of	  non-­‐antibiotic	  treatments	  for	  C.	  difficile	  reduces	  rates	  of	  VRE.	  
	  
	  
Chapter	  3:	  Data	  Sources	  	  
	   The	  data	  for	  this	  study	  comes	  from	  three	  sources,	  each	  covering	  a	  different	  aspect	  of	  C.	  difficile	  transmission.	  The	  data	  from	  these	  sources,	  as	  well	  as	  estimates	  from	  the	  literature,	  inform	  the	  parameter	  estimates	  used	  in	  the	  mathematical	  model	  described	  in	  later	  chapters.	  
Individual	  level	  C.	  difficile	  cohort	  
	   A	  cohort	  of	  609	  patients	  over	  18	  years	  of	  age	  was	  drawn	  from	  patients	  in	  28	  hospitals	  within	  the	  DICON	  network	  with	  incident,	  hospital-­‐onset,	  healthcare	  facility-­‐associated	  CDI,	  as	  defined	  by	  the	  CDC	  surveillance	  criteria40	  between	  7/1/2009	  and	  12/31/2010	  (Figure	  3-­‐1).	  	  
This	  data	  set	  included	  patient	  admission,	  discharge,	  laboratory-­‐based	  diagnosis	  times,	  outcomes	  including	  death	  and	  discharge,	  and	  patient	  demographics	  and	  whether	  or	  not	  the	  case	  arose	  while	  the	  patient	  was	  in	  an	  intensive	  care	  unit	  (ICU).	  These	  data	  are	  used	  to	  quantify	  and	  describe	  the	  outcomes	  of	  individual	  patients	  once	  they	  develop	  CDI,	  such	  as	  their	  average	  length	  of	  stay,	  all-­‐cause	  case	  fatality	  rates,	  etc.	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Hospital	  level	  C.	  difficile	  surveillance	  
	   The	  patient-­‐level	  CDI	  cohort	  is	  supplemented	  by	  a	  weekly	  surveillance	  time-­‐series	  of	  31	  hospitals	  within	  the	  DICON	  network,	  consisting	  of	  the	  overall	  number	  of	  hospital-­‐onset,	  healthcare	  facility-­‐associated	  cases	  over	  the	  same	  time	  period	  of	  7/1/2009	  to	  12/31/2010.	  In	  addition	  to	  the	  overall	  burden	  in	  terms	  of	  number	  of	  cases,	  this	  data	  set	  includes	  patient-­‐day	  denominators	  for	  the	  hospital	  overall	  and	  within	  the	  ICU	  specifically,	  as	  well	  as	  whether	  or	  not	  the	  hospital	  was	  using	  polymerase	  chain	  reaction	  (PCR)	  or	  non-­‐molecular	  diagnostic	  tests	  to	  diagnose	  cases.	  In	  total,	  this	  surveillance	  time	  series	  consisted	  of	  1805	  CDI	  cases	  over	  4,038,447	  patient	  days,	  344,471	  of	  which	  were	  within	  the	  ICU.	  This	  data	  set’s	  primary	  utility	  is	  in	  describing	  the	  overall	  incidence	  of	  CDI	  within	  a	  hospital.	  As	  some	  parameters	  in	  the	  model	  are	  unknown,	  and	  the	  model	  largely	  based	  on	  disparate	  information	  sources,	  it	  is	  useful	  to	  verify	  that	  the	  burden	  of	  disease	  as	  seen	  in	  the	  model	  corresponds,	  at	  least	  roughly,	  to	  the	  burden	  of	  disease	  experienced	  by	  actual	  hospitals.	  
Non-­‐CDI	  Patient	  data	  
	   The	  datasets	  above	  describe,	  at	  varying	  levels	  of	  aggregation,	  the	  experience	  of	  CDI	  patients	  within	  the	  DICON	  hospitals.	  However,	  a	  mathematical	  model	  of	  C.	  
difficile	  transmission	  requires	  information	  about	  the	  disposition	  of	  presently	  healthy	  patients	  within	  the	  hospital	  –	  how	  they	  are	  prescribed	  drugs	  that	  put	  them	  at	  risk	  for	  CDI,	  admissions	  and	  discharge	  rates,	  etc.	  	  A	  data	  set	  of	  billing	  records	  for	  all	  inpatients	  within	  the	  UNC	  Healthcare	  System	  was	  obtained	  for	  patients	  admitted	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between	  7/1/2009	  and	  12/31/2010.	  This	  data	  set	  contained	  the	  records	  of	  42,093	  patients,	  452	  of	  which	  were	  in	  the	  ICU,	  and	  included	  demographic	  information,	  admission	  and	  discharge	  times,	  complaints	  present	  on	  admission,	  and	  flags	  for	  prescriptions	  that	  might	  place	  a	  patient	  at	  risk	  for	  the	  development	  of	  CDI	  (Table	  3-­‐1).	  
	  
Figure	  3-­‐1.	  CDC/NHSN	  timeline-­‐based	  C.	  difficile	  surveillance	  definitions.	  C.	  difficile	  infections	  are	  divided	  into	  one	  of	  four	  categories:	  Healthcare	  Facility	  Onset-­‐Healthcare	  Facility	  Associated	  (HO-­‐HCFA),	  Community	  Onset-­‐Healthcare	  Facility	  Associated	  (CO-­‐HCFA),	  Indeterminate	  or	  Community	  Associated	  (CA-­‐CDAD)	  cases	  based	  on	  the	  time	  of	  onset	  of	  disease.	  Patients	  developing	  CDI	  within	  48	  hours	  of	  admission	  are	  considered	  CO-­‐HCFA	  if	  they	  had	  a	  previous	  discharge	  from	  a	  healthcare	  facility	  within	  4	  weeks,	  CA-­‐CDAD	  otherwise.	  	  
Table	  3-­‐1.	  Drug	  Prescriptions	  for	  UNC	  Healthcare	  System	  Inpatients	  Identified	  as	  High-­‐Risk	  for	  Development	  of	  Clostridium	  difficile	  Infection	   	  
48#hrs# 4#Weeks# 8#Weeks#





Brand	  Name	   Generic	  Drug	  Name	   Type	  Ciloxan	   Ciprofloxacin	   Fluoroquinolone	  Cipro	   Ciprofloxacin	   Fluoroquinolone	  Floxin	   Ofloxacin	   Fluoroquinolone	  Levaquin	   Levofloxacin	   Fluoroquinolone	  Nexium	   Esomeprazole	  Magnesium	   Proton	  Pump	  Inhibitor	  Noroxin	   Norfloxacin	   Fluoroquinolone	  Ofloxacin	   Ofloxacin	   Fluoroquinolone	  Omeprazole	   Omeprazole	   Proton	  Pump	  Inhibitor	  Prevacid	   Lansoprazole	   Proton	  Pump	  Inhibitor	  Prilosec	   Omeprazole	   Proton	  Pump	  Inhibitor	  Protonix	   Pantoprazole	  Sodium	   Proton	  Pump	  Inhibitor	  Vigamox	   Moxifloxacin	   Fluoroquinolone	  
	  
	  
Chapter	  4:	  Estimating	  All-­‐Cause	  Mortality	  and	  Length	  of	  
Stay	  in	  Incident,	  Healthcare	  Facility-­‐associated	  Clostridium	  
difficile	  Cases	  Using	  Parametric	  Mixture	  Models	  	  
Introduction	  
Clostridium	  difficile	  infection	  (CDI)	  is	  a	  rapidly	  increasing	  cause	  of	  healthcare-­‐associated	  infections	  (HAI).	  Discharge	  data	  from	  the	  Healthcare	  Cost	  and	  Utilization	  Project	  Nationwide	  Inpatient	  Sample	  demonstrated	  that	  approximately	  336,000	  cases	  of	  CDI	  occur	  annually	  in	  the	  US41.	  This	  number	  of	  cases	  would	  cost	  approximately	  $500	  million	  per	  year5,6.	  In	  contrast	  to	  other	  HAI,	  CDI	  incidence	  has	  actually	  increased	  despite	  prevention	  efforts	  in	  the	  US,	  Canada	  and	  Europe4.	  	  	  
The	  design	  and	  analysis	  of	  interventions	  to	  control	  C.	  difficile	  is	  complicated	  by	  the	  setting	  in	  which	  infection	  takes	  place.	  Hospitalized	  patients	  are	  often	  non-­‐independent,	  single	  intervention	  studies	  are	  rare	  and	  difficult	  to	  conduct,	  and	  infected	  patients	  act	  as	  a	  source	  of	  exposure	  for	  other	  patients,	  in	  addition	  to	  having	  their	  own	  outcomes.	  In	  this	  kind	  of	  environment,	  mathematical	  and	  cost-­‐effectiveness	  models	  are	  widely	  used,	  and	  hospital	  policy	  set	  on	  scarce	  data.	  There	  is	  a	  need	  for	  unbiased	  epidemiological	  estimates	  of	  patient	  outcomes,	  including	  length	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of	  stay,	  all-­‐cause	  mortality,	  and	  other	  estimates	  that	  quantify	  the	  experience	  of	  a	  patient	  suffering	  from	  CDI.	  
Quantifying	  these	  outcomes	  presents	  a	  three-­‐fold	  problem.	  First,	  infection	  events	  cannot	  be	  considered	  independent,	  necessitating	  analytic	  techniques	  that	  account	  for	  clustering	  within	  a	  hospital.	  Second,	  to	  facilitate	  the	  use	  of	  these	  estimates	  in	  mathematical	  models,	  cost-­‐effectiveness	  research,	  and	  other	  applications,	  rates	  or	  hazards	  must	  be	  directly	  estimated.	  Finally,	  patients	  may	  experience	  several	  mutually	  exclusive	  outcomes	  (such	  as	  death	  or	  discharge	  from	  the	  hospital).	  To	  address	  this	  final	  problem	  competing	  risks	  approaches	  must	  be	  employed.	  Conventional	  competing	  risk	  analysis	  (i.e.,	  a	  cause-­‐specific	  survival	  model)	  estimates	  the	  time	  to	  one	  outcome,	  while	  treating	  the	  other	  outcomes	  as	  censored42.	  These	  estimates	  address	  a	  particular	  question;	  namely,	  in	  the	  case	  of	  death	  versus	  discharge	  from	  a	  hospital,	  they	  estimate	  the	  time	  until	  death	  if	  no	  one	  were	  ever	  discharged	  or	  the	  time	  until	  discharge	  if	  no	  one	  ever	  died	  while	  in	  the	  hospital.	  While	  in	  some	  settings	  this	  approach	  might	  be	  acceptable	  or	  even	  desirable,	  in	  the	  case	  of	  CDI	  we	  wish	  to	  estimate	  the	  time	  until	  death	  given	  the	  observed	  levels	  of	  discharge,	  and	  the	  time	  until	  discharge	  given	  the	  observed	  levels	  of	  mortality.	  
In	  this	  study	  we	  describe	  an	  application	  of	  parametric	  mixture	  survival	  models	  to	  estimate	  two	  survival	  outcomes	  and	  address	  the	  problems	  enumerated	  above.	  We	  model	  the	  relative	  survival	  times	  of	  death	  from	  any	  cause	  and	  discharge	  between	  patients	  in	  the	  intensive	  care	  unit	  (ICU)	  and	  those	  in	  the	  general	  hospital	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population	  from	  a	  multi-­‐hospital	  cohort	  of	  CDI	  patients.	  In	  addition	  to	  the	  relative	  survival	  times	  between	  those	  patient	  groups,	  we	  also	  estimate	  the	  proportion	  that	  die	  while	  in	  the	  hospital	  for	  ICU	  patients	  and	  non-­‐ICU	  patients	  and	  the	  odds	  ratio	  for	  those	  proportions.	  
Materials	  and	  Methods	  
Study	  Population	  
We	  used	  a	  cohort	  of	  609	  adult	  (>18	  years	  of	  age)	  incident	  cases	  of	  CDI	  admitted	  between	  7/1/2009	  and	  12/31/2010	  obtained	  from	  infection	  control	  surveillance	  data	  from	  28	  hospitals	  within	  the	  Duke	  Infection	  Control	  Outreach	  Network,	  a	  group	  of	  hospitals	  that	  shares	  infection	  control	  expertise	  and	  data	  in	  the	  southeastern	  United	  States43.	  The	  maximum	  number	  of	  cases	  from	  a	  single	  hospital	  was	  74,	  the	  minimum	  1,	  and	  the	  median	  number	  of	  cases	  per	  hospital	  was	  13.	  All	  cases	  were	  hospital	  onset,	  healthcare	  facility-­‐associated,	  as	  defined	  by	  the	  CDC’s	  surveillance	  guidelines40.	  Specifically,	  cases	  must	  have	  arisen	  more	  than	  48	  hours	  after	  admission.	  
Survival	  Times	  and	  Outcomes	  
The	  study	  had	  two	  competing,	  mutually	  exclusive	  outcomes	  of	  interest:	  death	  from	  any	  cause	  and	  hospital	  discharge	  within	  180	  days.	  The	  origin	  of	  time	  at	  risk	  was	  defined	  as	  the	  date	  of	  a	  positive	  test	  for	  C.	  difficile.	  	  The	  event	  time	  was	  given	  as	  the	  date	  of	  discharge	  from	  the	  hospital	  or	  date	  of	  death.	  The	  single	  patient	  with	  an	  event	  time	  greater	  than	  180	  days	  was	  censored	  at	  180	  days,	  and	  the	  12	  patients	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with	  an	  unknown	  event	  time	  were	  considered	  interval	  censored	  from	  12	  hours	  after	  diagnosis	  to	  180	  days	  after	  diagnosis.	  Patients	  with	  identical	  diagnosis	  and	  discharge	  dates	  were	  assumed	  to	  spend	  12	  hours	  in	  the	  hospital.	  
Exposure	  Definition	  and	  Covariate	  Selection	  
Patient	  ICU	  status	  was	  determined	  at	  the	  time	  of	  diagnosis	  of	  CDI.	  Patients	  were	  either	  in	  the	  hospital’s	  ICU	  at	  the	  time	  of	  their	  infection	  and	  thus	  exposed	  or	  were	  not,	  and	  are	  unexposed,	  regardless	  of	  whether	  or	  not	  their	  treatment	  subsequently	  ended	  or	  involved	  the	  ICU.	  
Inverse	  probability	  weights	  were	  used	  to	  control	  for	  confounding	  by	  patient	  characteristics	  measured	  at	  hospital	  admission44.	  Using	  such	  weights,	  rather	  than	  regression	  adjustment,	  allows	  estimated	  curves	  to	  represent	  the	  marginal	  survival,	  rather	  than	  survival	  conditional	  on	  covariates45.	  Variables	  considered	  for	  inclusion	  in	  the	  model	  were	  patient	  age,	  whether	  or	  not	  they	  were	  on	  dialysis,	  if	  the	  patient	  had	  been	  hospitalized	  within	  12	  weeks	  prior	  to	  admission,	  if	  that	  prior	  admission	  had	  been	  in	  the	  same	  institution	  as	  the	  current	  admission,	  if	  the	  patient	  had	  been	  previously	  diagnosed	  with	  C.	  difficile,	  the	  patient’s	  gender	  and	  race,	  source	  of	  admission	  (where	  the	  patient	  was	  prior	  to	  admission),	  which	  medical	  specialty	  was	  primarily	  responsible	  for	  the	  patient	  (i.e.	  medicine,	  surgery,	  obstetrics/gynecology,	  etc.),	  if	  the	  patient	  had	  been	  discharged	  from	  any	  hospital	  within	  the	  past	  year,	  and	  whether	  the	  CDI	  case	  was	  a	  new	  episode,	  a	  recurrent	  episode,	  or	  a	  continuation	  per	  CDC	  definitions.	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Potential	  confounders	  were	  included	  in	  the	  weighting	  model	  if	  they	  were	  marginally	  associated	  (p<0.20)	  with	  either	  death	  or	  discharge	  using	  a	  Weibull	  or	  log-­‐normal	  parametric	  survival	  model,	  respectively.	  A	  quadratic	  term	  for	  the	  sole	  continuous	  variable	  (age	  at	  admission)	  and	  bivariate	  interactions	  that	  marginally	  improved	  model	  fit	  as	  evaluated	  by	  a	  likelihood	  ratio	  rest	  (p<0.20)	  were	  included.	  Multiple	  imputation	  was	  used	  to	  handle	  missing	  covariate	  values,	  which	  resulted	  in	  119	  cases	  with	  at	  least	  one	  missing	  variable.	  Thirty	  imputations	  were	  based	  on	  a	  multivariate	  normal	  model	  including	  all	  variables	  used	  in	  the	  substantive	  analysis,	  including	  outcomes.	  Imputations	  were	  combined	  using	  Rubin’s	  canonical	  variance	  estimator46.	  
Parametric	  Mixture	  Model	  
We	  modeled	  time	  to	  death	  and	  time	  to	  discharge	  as	  a	  mixed	  survival	  function,	  
SD(t)	  and	  SN(t)	  respectively,	  where	  	  SD(t)	  +	  SN(t)	  =	  1	  at	  t	  =	  ∞,	  indicating	  all	  patients	  having	  experienced	  one	  of	  the	  two	  outcomes	  of	  interest.	  These	  two	  functions,	  as	  well	  as	  the	  proportion	  of	  patients	  who	  died	  (π)	  and	  who	  were	  discharged	  (1-­‐π)	  give	  a	  probability	  that	  an	  event	  time	  T	  taking	  place	  at	  T	  <	  t	  of	  P(T	  <	  t)	  =	  π[1-­‐SD(t)]	  +	  (1-­‐	  π)[1-­‐SN(t)].	  Details	  on	  the	  theory	  and	  implementation	  of	  this	  type	  of	  model	  have	  been	  previously	  published47.	  Briefly,	  these	  functions	  can	  be	  estimated	  using	  maximum	  likelihood	  methods,	  with	  the	  likelihood	  of	  a	  given	  individual	  i	  expressed	  as	  follows	  (Equation	  2):	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Where	  fD(t)	  and	  fN(t)	  are	  the	  probability	  density	  functions	  for	  death	  and	  discharge,	  δ	  and	  θ	  are	  indicators	  for	  death	  =	  1	  and	  discharge	  =	  1,	  and	  ζ	  and	  η	  are	  indicators	  for	  interval	  censored	  times	  for	  death	  and	  discharge.	  For	  interval	  censored	  observations,	  ti1	  and	  ti2	  indicate	  the	  two	  times	  bracketing	  the	  censored	  interval,	  where	  ti1	  <	  ti2	  and	  in	  this	  study	  specifically,	  ti1	  =	  0.5	  and	  ti2	  =	  180	  days.	  Weighting	  is	  incorporated	  by	  multiplying	  the	  natural	  log	  of	  Li	  by	  individual	  i’s	  weight.	  	  
	   The	  survival	  functions	  used	  in	  the	  mixture	  model	  may	  be	  any	  parametric	  functions.	  Previous	  studies	  have	  used	  exponential48,	  log-­‐normal49,	  and	  generalized	  gamma	  survival	  functions50,	  differing	  functions	  for	  each	  outcome47,	  and	  non-­‐parametric	  extensions	  of	  the	  Kaplan-­‐Meier	  method51,	  among	  others.	  In	  this	  study,	  a	  Weibull	  function	  for	  death	  and	  a	  log-­‐normal	  function	  for	  discharge	  were	  used.	  This	  choice	  mirrored	  the	  best	  fitting	  parametric	  models	  used	  in	  the	  single	  outcome	  models	  discussed	  below,	  and	  in	  the	  confounder	  selection	  process.	  	  
Robust	  standard	  errors	  with	  clustering	  by	  hospital	  were	  calculated	  to	  account	  for	  non-­‐independence	  between	  patients	  in	  the	  same	  hospital.	  From	  this	  model,	  five	  main	  estimates	  are	  obtained:	  The	  ratios	  of	  the	  mean	  survival	  times	  for	  death	  (RTD)	  and	  discharge	  (RTN)	  between	  the	  ICU	  cases	  and	  non-­‐ICU	  cases,	  the	  proportions	  who	  died	  in	  hospital	  for	  the	  ICU	  cases	  and	  non-­‐ICU	  cases	  (π1	  and	  π0,	  
Li = [π i fD (ti )]δ i (1−ζ i ) × [π i (SD (ti1)− SD (ti2 ))]δ iζ i × [(1−π i ) fN (ti )]θi (1−ηi ) ×
[(1−π i )(SN (ti1)− Sn (ti2 ))]θiηi × [π iSD (ti )+ (1−π i )SN (ti )]1−δ i−θi
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respectively)	  and	  the	  odds	  ratio	  of	  the	  mixing	  proportions	  (ORπ),	  which	  provides	  a	  relative	  measure	  of	  mortality	  between	  the	  ICU	  groups.	  
For	  comparison	  purposes,	  the	  cohort	  was	  also	  analyzed	  using	  conventional	  competing	  risks	  analysis,	  with	  each	  outcome	  modeled	  independently	  and	  patients	  experiencing	  the	  other	  event	  being	  considered	  censored	  at	  their	  event	  time.	  A	  parametric	  Weibull	  survival	  model	  was	  used	  to	  model	  time	  until	  death,	  and	  a	  log-­‐normal	  survival	  model	  used	  to	  model	  discharge.	  	  As	  with	  the	  mixture	  model,	  robust	  standard	  errors	  were	  used	  to	  account	  for	  non-­‐independence	  arising	  from	  clustering	  by	  hospital.	  All	  analysis	  was	  done	  using	  SAS	  9.2	  (SAS	  Institute,	  Cary,	  NC).	  
Results	  
The	  characteristics	  of	  the	  ICU	  and	  non-­‐ICU	  patient	  populations	  are	  summarized	  in	  Table	  4-­‐1.	  There	  were	  160	  (26.2%)	  ICU	  patients	  and	  449	  (73.7%)	  non-­‐ICU	  patients.	  In	  the	  ICU	  population,	  42	  patients	  (26.3%)	  died,	  while	  in	  the	  non-­‐ICU	  population	  43	  patients	  (9.6%)	  died.	  The	  remaining	  patients	  were	  discharged	  from	  the	  hospital.	  Figure	  4-­‐1	  provides	  a	  graphical	  depiction	  of	  the	  distribution	  of	  exposures,	  outcomes	  and	  survival	  times	  in	  a	  20%	  random	  sample	  of	  the	  cohort.	  
Several	  factors	  were	  at	  least	  moderately	  associated	  with	  one	  of	  the	  two	  outcomes,	  including	  the	  patient’s	  age,	  gender	  and	  race,	  along	  with	  the	  source	  of	  admission,	  whether	  or	  not	  they	  were	  a	  surgical	  patient,	  if	  the	  patient	  was	  on	  dialysis,	  and	  whether	  or	  not	  this	  was	  a	  new	  case	  of	  CDI	  (in	  contrast	  to	  a	  continuing	  or	  recurrent	  case)	  (Table	  4-­‐2).	  Interactions	  between	  patient’s	  race	  and	  gender,	  age,	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whether	  or	  not	  this	  was	  a	  new	  CDI	  case,	  and	  dialysis	  status,	  between	  patient’s	  gender	  and	  both	  surgical	  and	  dialysis	  status	  and	  between	  admission	  source	  and	  patient	  age	  and	  dialysis	  status	  were	  also	  found	  to	  result	  in	  moderately	  superior	  model	  fit	  for	  the	  outcome	  specific	  models.	  
Parametric	  Survival	  Models	  
Using	  a	  conventional	  competing	  risks	  approach,	  the	  relative	  time	  to	  death	  for	  the	  ICU	  versus	  non-­‐ICU	  populations,	  RTD	  was	  0.65	  (95%	  CI:	  0.36,	  1.17),	  suggesting	  that	  ICU	  patients	  died	  marginally	  more	  swiftly	  than	  their	  counterparts	  in	  the	  general	  hospital	  population.	  Concurrently,	  the	  relative	  time	  until	  discharge,	  RTN	  was	  2.30	  (1.66,	  3.18),	  reflecting	  longer	  lengths	  of	  stay	  within	  the	  exposed	  population	  (Figure	  4-­‐2).	  
The	  mixing	  proportion	  in	  the	  ICU	  population	  (π1)	  was	  0.28	  while	  the	  mixing	  proportion	  in	  the	  non-­‐ICU	  population	  (π0)	  was	  0.10.	  The	  odds	  ratio	  of	  the	  mixing	  proportions	  (ORπ)	  was	  3.38	  (95%	  CI:	  1.84,	  6.19),	  capturing	  the	  substantially	  higher	  burden	  of	  mortality	  in	  ICU	  patients	  compared	  to	  those	  in	  the	  general	  hospital	  population.	  Comparing	  the	  mean	  event	  times	  between	  ICU	  and	  non-­‐ICU	  patients,	  RTD	  was	  1.97	  (95%	  CI:	  0.96,	  4.01)	  and	  RTN	  was	  1.88	  (95%	  CI:	  1.40,	  2.51)	  (Figure	  4-­‐3).	  	  
The	  robust	  standard	  errors	  typically	  resulted	  in	  a	  slight	  inflation	  of	  a	  parameter’s	  uncertainty	  and	  performed	  similarly	  to	  standard	  errors	  obtained	  using	  a	  nonparametric	  bootstrap	  method	  (not	  shown).	  Compared	  to	  the	  multiply	  imputed	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data	  used	  in	  the	  primary	  analysis,	  estimates	  using	  complete	  cases	  were	  less	  precise	  and	  resulted	  in	  considerably	  different	  effect	  estimates	  (Table	  4-­‐3).	  
These	  estimates,	  in	  contrast	  to	  those	  from	  the	  conventional	  models	  described	  above,	  indicate	  that	  despite	  the	  higher	  severity	  of	  illness	  that	  might	  reasonably	  be	  assumed	  in	  patients	  admitted	  to	  the	  ICU,	  they	  experience	  longer	  times	  to	  both	  death	  and	  discharge	  than	  patients	  in	  the	  general	  hospital	  population.	  The	  differences	  in	  estimates	  between	  the	  two	  models	  are	  summarized	  in	  Table	  4-­‐4.	  
Discussion	  
The	  purpose	  of	  this	  study	  was	  to	  examine	  the	  outcomes	  experienced	  by	  patients	  with	  CDI	  as	  a	  mixture	  of	  two	  simultaneously	  occurring	  survival	  processes,	  rather	  than	  as	  two	  disjoint	  events.	  We	  believe	  that	  this	  approach	  captures	  the	  actual	  disposition	  of	  patients	  within	  the	  hospital	  in	  a	  more	  realistic	  fashion.	  The	  use	  of	  a	  weighted,	  parametric	  mixture	  model	  allows	  for	  the	  estimation	  and	  prediction	  of	  survival	  times,	  produces	  marginal	  effect	  estimates	  and	  covariate	  adjusted	  survival	  curves	  and	  is	  free	  from	  the	  proportional	  hazards	  assumption.	  This	  assumption	  is	  however	  exchanged	  for	  the	  necessity	  of	  correctly	  specifying	  the	  underlying	  distribution	  of	  event	  times	  as	  well	  as	  proportional	  survival	  times.	  
This	  method	  also	  illustrates	  the	  potential	  for	  incorrect	  estimation	  in	  conventional	  survival	  analysis	  when	  both	  outcomes	  are	  of	  interest	  for	  informing	  prevention	  efforts.	  The	  conventional	  competing	  risks	  model	  found	  a	  reduced	  time	  until	  death	  for	  ICU	  patients.	  In	  essence,	  this	  method	  conflates	  the	  proportion	  of	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patients	  who	  died	  with	  the	  time	  with	  which	  it	  took	  them	  to	  die.	  In	  our	  study,	  the	  mixture	  approach	  separates	  these	  two	  processes	  into	  two	  separately	  estimated	  parameters.	  In	  doing	  so,	  our	  study	  suggests	  that	  while	  ICU	  patients	  may	  experience	  a	  greater	  burden	  of	  mortality,	  their	  survival	  times	  appear	  longer.	  The	  conventionally	  estimated	  RTD	  of	  0.65	  (95%	  CI:	  0.36,	  1.17)	  is	  not	  only	  on	  the	  other	  side	  of	  the	  null	  from	  the	  RTD	  estimated	  in	  the	  mixture	  model,	  1.97	  (0.96,	  4.01),	  but	  does	  not	  include	  the	  mixture	  model’s	  point	  estimate	  within	  its	  95%	  confidence	  interval.	  The	  origin	  of	  this	  difference	  is	  in	  the	  survival	  functions	  estimated	  by	  the	  two	  methods.	  The	  conventional	  method	  forces	  the	  survival	  functions	  for	  both	  outcomes	  to	  equal	  zero	  at	  t	  =	  ∞,	  whereas	  the	  mixture	  approach	  only	  forces	  the	  functions	  to	  equal	  the	  mixing	  proportion	  of	  their	  respective	  outcomes	  at	  t	  =	  ∞,	  a	  less	  stringent	  requirement.	  By	  treating	  patients	  who	  did	  not	  experience	  the	  outcome	  as	  censored,	  the	  conventional	  approach	  also	  pushes	  the	  estimated	  survival	  functions	  out	  toward	  the	  tail	  of	  their	  distribution.	  This	  difference	  in	  the	  shape	  of	  the	  survival	  curves	  manifests	  itself	  as	  drastically	  different	  survival	  probabilities.	  For	  example,	  the	  probability	  of	  death	  at	  90	  days	  is	  0.275	  for	  ICU	  and	  0.014	  for	  non-­‐ICU	  patients	  in	  the	  mixture	  model,	  and	  0.765	  for	  ICU	  and	  0.622	  for	  non-­‐ICU	  patients	  using	  a	  conventional	  approach.	  These	  differences	  in	  the	  estimated	  survival	  functions	  are	  the	  source	  of	  the	  disparate	  estimates	  of	  RTD	  and	  RTN.	  The	  potential	  downstream	  effects	  of	  such	  a	  difference	  in	  the	  estimated	  survival	  times	  on	  administrative	  decisions,	  mathematical	  or	  cost-­‐effectiveness	  models,	  etc.	  are	  significant.	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Focusing	  on	  the	  results	  of	  the	  parametric	  mixture	  model,	  this	  study	  demonstrated	  that	  ICU	  patients	  infected	  with	  C.	  difficile	  experience	  both	  longer	  times	  until	  death	  and	  longer	  overall	  lengths	  of	  stay	  post-­‐infection,	  as	  well	  as	  experiencing	  a	  burden	  of	  mortality	  three	  times	  that	  of	  their	  non-­‐ICU	  peers.	  The	  study	  estimates	  suggest	  that	  ICUs	  demand	  additional	  resources	  and	  attention	  from	  an	  invention	  prevention	  perspective,	  despite	  C.	  difficile	  being	  a	  hospital-­‐wide	  problem,	  unlike	  HAIs	  associated	  with	  a	  particular	  device	  or	  procedure.	  The	  ICU	  has	  a	  proportionately	  large	  volume	  of	  adverse	  outcomes,	  and	  ICU	  patients	  longer	  length	  of	  stay	  may	  contribute	  more	  to	  the	  contamination	  of	  the	  hospital	  environment	  and	  have	  implications	  for	  impacting	  in-­‐hospital	  transmission	  of	  CDI.	  	  Patients	  have	  been	  shown	  to	  shed	  C.	  difficile	  into	  the	  environment	  continuously	  after	  infection,	  even	  after	  their	  symptoms	  have	  subsided52.	  Because	  of	  their	  longer	  time	  within	  the	  hospital,	  ICU	  patients	  have	  increased	  opportunities	  to	  shed	  C.	  difficile	  spores	  into	  the	  environment.	  Whether	  this	  higher	  individual-­‐level	  potential	  for	  shedding	  is	  outweighed	  by	  the	  considerably	  larger	  number	  of	  spore-­‐shedding	  patients	  within	  the	  general	  hospital	  population	  who	  are	  hospitalized	  for	  shorter	  time	  periods	  warrants	  further	  examination.	  
	   This	  study	  has	  several	  limitations.	  Though	  the	  surveillance	  data	  used	  has	  information	  on	  whether	  or	  not	  a	  given	  patient	  died	  within	  the	  hospital,	  it	  cannot	  necessarily	  be	  assumed	  that	  these	  deaths	  were	  attributable	  to	  C.	  difficile,	  either	  solely	  or	  as	  part	  of	  a	  constellation	  of	  ailments.	  Rather	  than	  an	  estimation	  of	  the	  impact	  of	  CDI	  on	  patient	  mortality,	  this	  study	  is	  instead	  an	  estimation	  of	  the	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patient’s	  potential	  impact	  on	  the	  hospital’s	  environment	  during	  their	  infection,	  until	  it	  is	  interrupted	  favorably	  by	  a	  discharge	  from	  the	  hospital	  or	  unfavorably	  by	  the	  patient’s	  death.	  While	  less	  patient-­‐centric	  than	  many	  studies,	  these	  types	  of	  estimates	  are	  crucial	  for	  the	  study	  and	  prevention	  of	  hospital	  acquired	  infections,	  where	  patients	  are	  not	  only	  important	  in	  the	  prevention	  of	  their	  own	  adverse	  outcomes,	  but	  represent	  sources	  of	  infection	  risk	  to	  future	  patients.	  
Additionally,	  as	  patients	  who	  have	  been	  discharged	  from	  the	  hospital	  may	  experience	  a	  recurrent	  infection	  and	  die,	  be	  treated	  outside	  the	  DICON	  network,	  or	  be	  readmitted	  into	  a	  DICON	  hospital	  with	  a	  different	  exposure	  status	  than	  their	  original	  infection,	  some	  outcome	  misclassification	  may	  have	  occurred.	  These	  limitations	  are	  however	  inherent	  to	  the	  difficult	  task	  of	  conducting	  observational	  studies	  within	  a	  hospital	  setting	  and	  occur	  regardless	  of	  what	  analytical	  methods	  are	  used.	  	  
Our	  approach,	  which	  allows	  for	  the	  separate	  estimation	  of	  the	  timing	  of	  an	  event	  and	  the	  frequency	  with	  which	  it	  occurs,	  provides	  a	  more	  nuanced	  view	  of	  the	  outcomes	  experienced	  by	  CDI	  patients.	  As	  interest	  in	  healthcare	  associated	  infection	  prevention	  increases,	  so	  too	  does	  the	  need	  for	  more	  sophisticated	  analytic	  techniques	  to	  reflect	  the	  complexity	  surrounding	  patients,	  providers,	  and	  the	  environment	  of	  a	  healthcare	  facility.	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Table	  4-­‐1.	  Baseline	  Characteristics	  of	  609	  Incident	  Clostridium	  difficile	  Infection	  Cases	  Within	  the	  DICON	  Hospital	  Network,	  Southeastern	  USA,	  2009-­‐2010.	  	   ICU	   	   Non-­‐ICU	  
Variable	   N	   %	   Mean	  (SD)	   	   N	   %	   Mean	  (SD)	  
Age	  (Years)	   	   	   66.99	  (14.33)	   	   	   	   70.04	  (15.20)	  
Dialysis	   	   	   	   	   	   	   	  	  	  Yes	   21	   13.1	   	   	   37	   8.2	   	  	  	  No	   135	   84.4	   	   	   407	   90.7	   	  	  	  Missing	   4	   2.5	   	   	   5	   1.1	   	  
Gender	   	   	   	   	   	   	   	  	  	  Female	   66	   41.3	   	   	   218	   48.6	   	  	  	  Male	   83	   51.9	   	   	   187	   41.7	   	  	  	  Missing	   11	   6.9	   	   	   44	   9.8	   	  
Admission	  Source	   	   	   	   	   	   	   	  	  	  Home	   99	   61.9	   	   	   290	   64.6	   	  	  	  Nursing	  Home	   27	   16.9	   	   	   99	   22.1	   	  	  	  Hospital	   20	   12.5	   	   	   10	   2.2	   	  	  	  Other	   13	   8.1	   	   	   45	   10.0	   	  	  	  Missing	   1	   0.6	   	   	   5	   1.1	   	  
New	  CDI	  Episode	   	   	   	   	   	   	   	  
	  	  	  Yes	   156	   97.5	   	   	   440	   98.0	   	  	  	  	  Nod	   4	   2.5	   	   	   9	   2.0	   	  	  	  	  Missing	   0	   0	   	   	   0	   0	   	  
Race	   	   	   	   	   	   	   	  	  	  White	   83	   51.9	   	   	   241	   53.7	   	  	  	  Black	   58	   36.3	   	   	   108	   24.1	   	  	  	  Other	   3	   1.9	   	   	   11	   2.5	   	  	  	  Missing	   16	   10.0	   	   	   89	   19.8	   	  
Surgical	  Patient	   	   	   	   	   	   	   	  
	  	  Yes	   8	   5.0	   	   	   36	   8.0	   	  	  	  No	   139	   86.9	   	   	   361	   80.4	   	  	  	  Missing	   13	   8.1	   	   	   52	   11.6	   	  Abbreviations:	  SD,	  standard	  deviation;	  ICU,	  intensive	  care	  unit.	  DICON,	  Duke	  Infection	  Control	  Outreach	  Network;	  CDI,	  C.	  difficile	  infection..	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Table	  4-­‐2.	  Association	  Between	  Patient-­‐level	  Covariates	  and	  Time	  Until	  Death	  or	  Discharge	  in	  a	  Cohort	  of	  609	  Incident	  Clostridium	  difficile	  Infection	  Cases	  Within	  the	  DICON	  Hospital	  Network,	  Southeastern	  USA,	  2009-­‐2010.	  	   Death	   	   Discharge	  
Variable	   RTD	   95%	  CI	   P	  value*	   	   RTN	   95%	  CI	   P	  value*	  
Age	  (Years)	   0.98	   0.96,	  0.99	   0.005	   	   1.00	   0.99,	  1.01	   0.89	  
Dialysis	   	   	   0.98	   	   	   	   0.16	  	  	  Yes	   1.01	   0.54,	  1.89	   	   	   0.78	   0.56,	  1.10	   	  	  	  No	   ref	   	   	   	   ref	   	   	  
Gender	   	   	   	   	   	   	   	  	  	  Female	   0.98	  	   0.62,	  1.55	   	   	   0.79	  	   0.64,	  0.96	   	  	  	  Male	   ref	   	   	   	   ref	   	   	  
Admission	  Source	   	   	   0.93	   	   	   	   0.026	  	  	  Home	   0.91	  	   0.41,	  2.04	   	   	   0.99	  	   0.70,	  1.39	   	  	  	  Nursing	  Home	   0.91	  	   0.37,	  2.45	   	   	   0.97	  	   0.66,	  1.42	   	  	  	  Hospital	   1.08	  	   0.36.	  3.29	   	   	   2.00	  	   1.16,	  3.45	   	  	  	  Other	   ref	   	   	   	   ref	   	   	  
New	  CDI	  Episode	   	   	   0.66	   	   	   	   0.072	  
	  	  	  Yes	   1.30	  	   0.41,	  4.14	   	   	   0.77	  	   0.53,	  1.12	   	  	  	  	  Nod	   ref	   	   	   	   ref	   	   	  
Race	   	   	   0.11	   	   	   	   0.89	  	  	  White	   0.65	  	   0.16,	  2.64	   	   	   0.85	  	   0.44,	  1.64	   	  	  	  Black	   1.04	  	   0.24,	  4.46	   	   	   0.87	  	   0.44,	  1.70	   	  	  	  Other	   ref	   	   	   	   ref	   	   	  
Surgical	  Patient	   	   	   0.47	   	   	   	   0.17	  
	  	  Yes	   1.52	  	   0.49,	  4.67	   	   	   0.77	  	   0.53,	  1.12	   	  	  	  No	   ref	   	   	   	   ref	   	   	  Abbreviations:	  RTD,	  relative	  difference	  in	  mean	  time	  until	  death;	  RTN,	  relative	  difference	  in	  mean	  time	  until	  discharge;	  CI,	  confidence	  interval;	  DICON,	  Duke	  Infection	  Control	  Outreach	  Network;	  CDI,	  
C.	  difficile	  infection.	  	   	   	   	  	  	  	  	  	  	   	   	   	   	   	   	  	  	  	  	  	  	  	  *Chi-­‐square	  test	  of	  the	  overall	  effect	  of	  the	  variable	  on	  time	  to	  death	  or	  discharge	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Figure	  4-­‐2.	  Cause-­‐specific	  parametric	  survival	  curves	  for	  time	  until	  death	  (A)	  and	  time	  until	  discharge	  (B)	  by	  ICU-­‐exposure	  status	  in	  a	  cohort	  of	  609	  incident	  
Clostridium	  difficile	  Infection	  cases	  within	  the	  DICON	  hospital	  network,	  Southeastern	  USA,	  2009-­‐2010.	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Figure	  4-­‐3.	  Times	  to	  death	  and	  discharge	  estimated	  using	  parametric	  mixture	  models	  in	  a	  cohort	  of	  609	  incident	  Clostridium	  difficile	  Infection	  cases	  within	  the	  DICON	  hospital	  network,	  Southeastern	  USA,	  2009-­‐2010.	  Black	  lines	  denote	  ICU	  patients,	  while	  grey	  lines	  denote	  non-­‐ICU	  patients.	  Solid	  lines	  are	  1	  minus	  the	  survival	  function	  for	  death,	  and	  dashed	  lines	  are	  the	  survival	  function	  for	  discharge.	  
	  
Table	  4-­‐3.	  Difference	  in	  Estimates	  from	  Multiple-­‐Imputation	  versus	  Complete	  Cases	  Analysis	  for	  Time	  Until	  Death,	  Discharge,	  and	  Mixing	  Odds	  Ratio	  Comparing	  ICU	  patients	  to	  non-­‐ICU	  Patients	  From	  a	  Cohort	  of	  609	  Incident	  Clostridum	  difficile	  Infection	  Cases	  Within	  the	  DICON	  Hospital	  Network,	  Southeastern	  USA,	  2009-­‐2010.	  Model	   RTD	   95%	  CI	   RTN	  	   95%	  CI	   π1	   π0	   ORπ	  	   95%	  CI	  Complete	  Case*	   1.27	  	   0.59,	  2.74	   2.03	  	   1.36,	  3.05	   0.25	   0.10	   2.94	  	   1.18,	  7.33	  Multiple	  Imputation*	   1.97	  	   0.96,	  4.01	   1.88	  	   1.40,	  2.51	   0.28	   0.10	   3.38	  	   1.84,	  6.19	  Abbreviations:	  RTD,	  relative	  difference	  in	  mean	  time	  until	  death;	  RTN,	  relative	  difference	  in	  mean	  time	  until	  discharge;	  Rπ,	  odds	  ratio	  of	  mixing	  proportions	  in	  the	  ICU	  and	  non-­‐ICU	  patient	  population;	  CI,	  confidence	  interval;	  DICON,	  Duke	  Infection	  Control	  Outreach	  Network;	  CDI,	  C.	  difficile	  infection.	  *Adjusted	  for	  patient’s	  age,	  gender	  and	  race,	  location	  prior	  to	  admission,	  whether	  or	  not	  patient	  was	  a	  surgical	  patient	  or	  on	  dialysis,	  and	  if	  this	  was	  a	  new	  CDI	  episode.	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Table	  4-­‐4.	  Estimates	  Obtained	  for	  Time	  Until	  Death,	  Discharge,	  and	  Mixing	  Odds	  Ratio	  Comparing	  ICU	  patients	  to	  non-­‐ICU	  Patients	  From	  a	  Cohort	  of	  609	  Incident	  
Clostridum	  difficile	  Infection	  Cases	  Within	  the	  DICON	  Hospital	  Network,	  Southeastern	  USA,	  2009-­‐2010.	  Model	   RTD	   95%	  CI	   RTN	  	   95%	  CI	   π1	   π0	   ORπ	  	   95%	  CI	  Cause-­‐Specific	  	  (Crude)	   0.72	  	   0.39,	  1.35	   2.45	  	   1.86,	  3.25	   -­‐	   -­‐	   -­‐	   -­‐	  Cause-­‐Specific	  	  (Adjusted)*	   0.65	  	   0.36,	  1.17	   2.30	  	   1.66,	  3.18	   -­‐	   -­‐	   -­‐	   -­‐	  	   	   	   	   	   	   	   	   	  Mixture	  Model	  	  (Crude)	   2.24	  	   1.25,	  4.02	   2.01	  	   1.50,	  2.69	   0.26	   0.10	   3.36	  	   1.85,	  6.11	  Mixture	  Model	  (Adjusted)*	   1.97	  	   0.96,	  4.01	   1.88	  	   1.40,	  2.51	   0.28	   0.10	   3.38	  	   1.84,	  6.19	  Abbreviations:	  RTD,	  relative	  difference	  in	  mean	  time	  until	  death;	  RTN,	  relative	  difference	  in	  mean	  time	  until	  discharge;	  Rπ,	  odds	  ratio	  of	  mixing	  proportions	  in	  the	  ICU	  and	  non-­‐ICU	  patient	  population;	  CI,	  confidence	  interval;	  DICON,	  Duke	  Infection	  Control	  Outreach	  Network;	  CDI,	  C.	  difficile	  infection.	  *Adjusted	  for	  patient’s	  age,	  gender	  and	  race,	  location	  prior	  to	  admission,	  whether	  or	  not	  patient	  was	  a	  surgical	  patient	  or	  on	  dialysis,	  and	  if	  this	  was	  a	  new	  CDI	  episode.	  
	  	  
Chapter	  5:	  A	  Mathematical	  Model	  to	  Evaluate	  the	  Routine	  
Use	  of	  Fecal	  Transplantation	  to	  Prevent	  Incident	  and	  
Recurrent	  Clostridium	  difficile	  Infection	  	  
Introduction	  
Clostridium	  difficile	  is	  a	  frequent	  source	  of	  healthcare-­‐associated	  infection	  (HAI),	  especially	  among	  patients	  receiving	  treatment	  regimens	  involving	  antibiotics35	  or	  proton	  pump	  inhibitors	  (PPIs)53,54,	  or	  with	  other	  conditions	  involving	  the	  disruption	  of	  normal	  gut	  flora.	  The	  rate	  of	  C.	  difficile	  infection	  (CDI)	  in	  the	  United	  States	  has	  been	  steadily	  rising	  since	  2000,	  causing	  an	  estimated	  336,565	  cases	  in	  the	  United	  States	  in	  200941.	  In	  some	  healthcare	  facilities,	  CDI	  has	  eclipsed	  methicillin-­‐resistant	  Staphylococcus	  aureus	  as	  the	  leading	  source	  of	  HAIs4.	  Of	  special	  concern	  is	  the	  development	  of	  recurrent	  CDI,	  which	  may	  be	  a	  complicated,	  long-­‐term	  condition	  typified	  by	  repeated	  bouts	  of	  severe	  diarrhea	  that	  involves	  treatment	  with	  antibiotics	  such	  as	  oral	  vancomycin,	  fidaxomicin	  or	  metronidazole35.	  
	   Because	  altering	  the	  indigenous	  flora	  of	  the	  intestinal	  tract	  causes	  CDI,	  there	  has	  been	  an	  interest	  in	  recolonizing	  the	  intestinal	  tract	  with	  introduced	  donor	  bacteria	  obtained	  from	  either	  healthy	  donor	  stool55,56	  or	  synthesized	  as	  a	  pure	  culture57.	  This	  procedure,	  referred	  to	  as	  fecal	  microbiota	  transplantation	  (FMT),	  restores	  the	  bacterial	  ecology	  that	  typically	  keeps	  C.	  difficile	  in	  check.	  Both	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uncontrolled	  case	  reports56,57	  and	  a	  small	  clinical	  trial55	  have	  shown	  encouraging	  results;	  however	  FMT	  is	  still	  largely	  reserved	  for	  specialized	  intervention	  in	  difficult	  or	  refractory	  cases.	  Further,	  the	  implications	  of	  routine	  intestinal	  recolonization	  as	  a	  standard	  course	  of	  treatment	  for	  the	  prevention	  of	  recurrent	  or	  incident	  CDI	  has	  not	  been	  widely	  explored.	  
	   Mathematical	  models	  are	  ideal	  for	  studying	  such	  hypothetical	  scenarios.	  They	  can	  provide	  a	  repeatable,	  quantitative	  environment	  with	  which	  to	  evaluate	  evidence,	  guide	  policy	  creation,	  discover	  critical	  thresholds	  upon	  which	  the	  success	  of	  interventions	  may	  depend,	  and	  suggest	  new	  directions	  for	  observational	  studies	  and	  clinical	  trials.	  These	  strengths	  are	  difficult	  or	  impossible	  to	  duplicate	  with	  empirical	  research	  within	  a	  hospital.	  Critically,	  one	  patient’s	  outcome	  influences	  another’s	  exposure,	  which	  violates	  traditional	  statistical	  assumptions	  of	  independence.	  Finally,	  mathematical	  models	  are	  capable	  of	  scaling	  up	  the	  independent,	  individual	  level	  observations	  that	  emerge	  from	  clinical	  research	  up	  to	  the	  population	  level.	  In	  this	  way,	  we	  may	  study	  how	  these	  individuals	  interact	  with	  one	  another	  and	  influence	  the	  transmission	  process	  without	  a	  risk	  to	  patient	  safety.	  	   In	  order	  to	  evaluate	  the	  impact	  of	  routine	  intestinal	  flora	  recolonization	  in	  patients	  with	  CDI,	  we	  developed	  a	  mathematical	  model	  describing	  the	  transmission	  of	  C.	  difficile	  within	  an	  intensive	  care	  unit	  (ICU),	  with	  the	  capability	  to	  test	  the	  impact	  of	  FMT	  for	  prevention	  of	  recurrent	  C.	  difficile	  or	  initial	  infection	  due	  to	  in-­‐hospital	  transmission.	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Methods	  
Data	  Sources	  
Hospital	  data	  was	  obtained	  from	  three	  separate	  sources,	  all	  consisting	  of	  patient	  records	  between	  7/1/2009	  and	  12/31/2010.	  The	  first	  dataset	  was	  a	  cohort	  of	  609	  adult	  patients	  with	  incident	  CDI	  was	  extracted	  from	  prospectively	  collected	  HAI	  surveillance	  data	  from	  28	  community	  hospitals	  in	  the	  Duke	  Infection	  Control	  Outreach	  Network	  (DICON).	  This	  data	  set	  included	  admission,	  discharge	  and	  diagnosis	  times,	  and	  outcomes	  including	  death	  and	  discharge,	  and	  patient	  demographics.	  The	  second	  data	  set	  included	  weekly	  surveillance	  time-­‐series	  from	  31	  DICON-­‐affiliated	  hospitals	  within	  the	  DICON	  network,	  consisting	  of	  the	  overall	  number	  of	  hospital-­‐onset,	  healthcare	  facility	  associated	  CDI	  cases	  as	  defined	  by	  CDC	  surveillance	  criteria40,	  patient-­‐day	  denominator	  data	  for	  the	  hospital	  as	  a	  whole	  hospital	  patient-­‐day	  denominator	  data,	  ICU	  patient-­‐days,	  and	  whether	  the	  hospital	  was	  using	  a	  non-­‐molecular	  diagnostic	  test	  or	  a	  diagnostic	  test	  based	  on	  polymerase	  chain	  reaction	  (PCR).	  In	  total,	  these	  series	  consist	  of	  1805	  cases	  and	  344,471	  ICU	  patient-­‐days.	  Finally,	  a	  third	  data	  set	  included	  hospital	  billing	  records	  for	  452	  inpatients	  discharged	  from	  the	  ICU	  within	  the	  UNC	  Healthcare	  System,	  consisting	  of	  discharge	  times,	  orders	  for	  drugs	  that	  place	  patients	  are	  risk	  for	  CDI	  such	  as	  PPIs	  or	  fluoroquinolones,	  coded	  diagnoses	  present	  on	  admission	  and	  demographics.	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Transmission	  Model	  
The	  transmission	  of	  C.	  difficile	  through	  an	  intensive	  care	  unit	  was	  modeled	  as	  a	  series	  of	  compartments	  representing	  patient	  health	  and	  treatment	  states	  (Figure	  5-­‐1).	  Healthcare	  personnel	  (HCP)	  were	  modeled	  as	  being	  either	  Uncontaminated	  (US)	  or	  Contaminated	  (H),	  representing	  hands	  or	  gloves	  contaminated	  by	  vegetative	  C.	  
difficile	  or	  spores.	  Patients	  could	  be	  in	  one	  of	  six	  compartments.	  Compartment	  UP	  represented	  uncolonized	  patients	  who	  were	  not	  on	  high-­‐risk	  medications	  for	  CDI,	  and	  UA	  represented	  uncolonized	  patients	  who	  were	  on	  high-­‐risk	  medications.	  Similarly,	  CP	  and	  CA	  represented	  low-­‐	  and	  high-­‐risk	  patients	  who	  were	  previously	  exposed	  to	  the	  organism.	  Compartment	  D	  represented	  patients	  who	  have	  developed	  CDI.	  Finally,	  some	  of	  the	  scenarios	  we	  considered	  had	  an	  additional	  compartment,	  CT,	  which	  represented	  patients	  under	  prophylactic	  treatment	  using	  FMT	  to	  prevent	  an	  initial	  infection.	  
	   The	  interactions	  and	  transitions	  between	  these	  compartments	  are	  governed	  by	  a	  series	  of	  eight	  differential	  equations	  (Eq	  3):	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dUS
dt = ιH − ρσ PCP
US
N − ρσ DD
US
N − ρσ ACA
US




dt = ρσ PCP
US
N + ρσ DD
US
N + ρσ ACA
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N −φCA −κτCA −θACA +νCA (θP (UP +CP )+θA(UA +CA +CT )+ζD + γ D)
dCT
dt = φCA −κCT −θACT
dD
dt =κ (CP +CT )+κτCA −ζD +νD (θP (UP +CP )+θA(UA +CA +CT )+ζD + γ D)
       −γχ(1−ω )ηD −γχω (1−η)D −γ (1− χ )(1−ω )D −γ (1− χ )ωD
M =UA +Up +CA +Cp +CT + D
N =Us + H +UA +Up +CA +Cp +CT + D 	  
The	  definitions	  and	  values	  of	  the	  parameters	  in	  this	  model	  are	  detailed	  in	  a	  later	  section.	  
Patients	  were	  admitted	  into	  UP,	  UA,	  CP,	  CA	  or	  D.	  Colonized	  patients	  (CP	  and	  CA)	  and	  patients	  with	  CDI	  (D)	  shed	  infectious	  material	  that	  may	  contaminate	  hands	  of	  HCP,	  and	  uncontaminated	  patients	  (UP	  and	  UA)	  are	  subsequently	  colonized	  when	  cared	  for	  by	  HCP	  with	  contaminated	  hands.	  HCP	  could	  decontaminate	  their	  hands	  by	  washing	  them	  after	  contact	  with	  either	  the	  patient	  or	  the	  environment	  immediately	  surrounding	  them.	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As	  there	  is	  evidence	  of	  a	  surface	  contamination	  component	  to	  C.	  difficile	  transmission16,	  contacts	  between	  patients	  and	  HCP	  were	  modeled	  as	  direct	  care	  tasks,	  which	  could	  involve	  contact	  with	  the	  patient’s	  environment	  as	  well	  as	  physical	  interaction	  between	  the	  patient	  and	  HCP.	  Once	  colonized,	  patients	  could	  progress	  to	  CDI	  (CX	  to	  D).	  All	  patients	  were	  eventually	  discharged	  from	  the	  hospital.	  Three	  possible	  outcomes	  were	  tracked	  for	  patients	  with	  CDI	  –	  death,	  a	  healthy	  discharge,	  and	  a	  discharge	  that	  resulted	  in	  the	  development	  of	  recurrent	  CDI.	  
	   The	  model	  made	  several	  simplifying	  assumptions.	  First,	  all	  HCP	  were	  assumed	  to	  interact	  with	  all	  patients	  within	  the	  ICU,	  and	  patients	  were	  assumed	  not	  to	  interact	  with	  each	  other.	  It	  is	  not	  known	  whether	  disruption	  of	  intestinal	  flora	  places	  patients	  at	  greater	  risk	  for	  developing	  CDI	  once	  colonized	  or	  at	  greater	  risk	  of	  colonization	  and	  thus	  subsequent	  infection58,59.	  Therefore,	  colonization	  once	  exposed	  to	  C.	  difficile	  and	  development	  of	  infection	  after	  colonization	  is	  treated	  as	  a	  single	  process	  within	  the	  model.	  Additionally,	  we	  assumed	  that	  patients	  who	  were	  placed	  on	  antibiotics	  or	  PPIs	  were	  prescribed	  those	  medications	  immediately	  on	  arrival	  into	  the	  ICU.	  Additionally,	  we	  assumed	  that	  the	  medication-­‐induced	  disruption	  of	  the	  normal	  gut	  flora	  was	  immediate	  and	  lasted	  beyond	  the	  discontinuation	  of	  treatment.	  This	  effectively	  meant	  that	  once	  a	  patient	  became	  high	  risk,	  they	  remained	  so	  unless	  an	  active	  intervention	  (such	  as	  FMT)	  was	  made	  to	  recolonize	  their	  intestinal	  tract.	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Parameterization	  and	  Model	  Calibration	  
	   The	  transmission	  model	  was	  parameterized	  using	  a	  combination	  of	  estimates	  from	  the	  literature	  and	  the	  data	  sets	  discussed	  above.	  Specific	  values,	  and	  the	  sources	  they	  are	  derived	  from,	  are	  described	  in	  Table	  5-­‐1	  below.	  A	  more	  detailed	  discussion	  of	  parameterization	  may	  be	  found	  in	  Appendix	  A.	  
The	  underlying	  hazard	  of	  developing	  CDI	  for	  low-­‐risk	  patients	  was	  estimated	  by	  fitting	  a	  deterministic	  version	  of	  the	  mathematical	  model	  above	  to	  the	  DICON	  surveillance	  time	  series.	  Because	  the	  case	  counts	  were	  not	  ICU-­‐specific,	  the	  proportion	  of	  all	  reported	  cases	  in	  the	  time	  series	  data	  that	  arise	  within	  the	  ICU	  was	  assumed	  to	  be	  equal	  to	  the	  proportion	  of	  cases	  within	  the	  DICON	  cohort	  data	  that	  arose	  in	  the	  ICU.	  Hospitals	  that	  did	  not	  report	  individual	  level	  data	  within	  the	  cohort	  were	  assigned	  the	  proportion	  of	  the	  hospital	  with	  the	  closest	  number	  of	  total	  patient-­‐days.	  	  
Based	  on	  prior	  research	  indicating	  a	  56%	  increase	  in	  the	  number	  of	  reported	  cases	  within	  these	  hospitals	  that	  switched	  from	  non-­‐molecular	  to	  PCR	  diagnostic	  tests60,	  weeks	  where	  non-­‐molecular	  tests	  were	  in	  use	  had	  their	  case	  numbers	  inflated	  by	  1.56.	  These	  adjusted	  time	  series	  were	  then	  used	  to	  calculate	  an	  expected	  weekly	  rate	  for	  a	  twelve-­‐bed	  ICU	  (the	  size	  of	  ICU	  used	  in	  this	  model)	  and	  a	  corresponding	  estimate	  of	  cumulative	  incidence	  over	  the	  one	  and	  a	  half	  years	  the	  surveillance	  data	  was	  collected.	  The	  cumulative	  incidence	  curves	  for	  each	  hospital	  were	  then	  averaged	  and	  weighted	  by	  the	  total	  number	  of	  ICU	  patient-­‐days	  per	  hospital.	  This	  weighted	  average	  cumulative	  incidence	  curve	  was	  used	  as	  an	  estimate	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of	  a	  “typical”	  level	  of	  infection	  for	  the	  modeled	  ICU.	  The	  cumulative	  incidence	  produced	  by	  the	  mathematical	  model	  was	  then	  fit	  to	  this	  weighted	  curve	  using	  least-­‐squares	  regression	  to	  obtain	  an	  estimate	  of	  the	  hazard	  of	  developing	  CDI	  in	  colonized,	  low-­‐risk	  patients.	  
Simulations	  
The	  mathematical	  model	  described	  above	  was	  applied	  to	  a	  single	  twelve-­‐bed	  ICU	  consisting	  of	  single	  patient	  rooms	  with	  four	  registered	  nurses	  and	  a	  single	  intensivist,	  based	  on	  average	  size	  and	  staffing	  information	  and	  best-­‐practice	  guidelines	  for	  ICUs72-­‐74.	  Admissions	  were	  fixed	  to	  be	  equal	  to	  discharges	  to	  maintain	  a	  steady	  patient	  population.	  Several	  different	  potential	  treatment	  regimens	  were	  considered	  (Table	  5-­‐2).	  First,	  we	  created	  a	  baseline	  scenario,	  modeling	  no	  routine	  use	  of	  fecal	  transplantation.	  Second,	  we	  modeled	  a	  series	  of	  scenarios	  depicting	  the	  systematic	  use	  of	  FMT	  after	  CDI	  in	  order	  to	  prevent	  recurrent	  cases,	  treating	  20,	  40,	  60,	  80	  and	  100	  percent	  of	  cases.	  Third,	  we	  modeled	  a	  series	  of	  scenarios	  examining	  the	  use	  of	  FMT	  prophylactically	  to	  prevent	  incident	  infections,	  treating	  contaminated	  high-­‐risk	  (CA)	  patients	  immediately	  after	  the	  conclusion	  of	  their	  treatment	  regimen,	  moving	  them	  to	  a	  new,	  low-­‐risk	  category	  (CT).	  These	  scenarios	  considered	  treating	  20,	  40,	  60,	  80	  and	  100	  percent	  of	  all	  high-­‐risk	  patients	  or	  just	  those	  patients	  on	  fluoroquinolone	  antibiotics.	  	  Finally,	  both	  the	  second	  and	  third	  treatment	  strategies	  used	  in	  combination,	  treating	  with	  FMT	  patients	  both	  post-­‐CDI	  and	  post-­‐high	  risk	  medication.	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Deterministic	  models	  do	  not	  fully	  capture	  the	  transmission	  dynamics	  of	  small	  populations,	  such	  as	  the	  experience	  of	  a	  single,	  12-­‐bed	  ICU.	  Therefore,	  each	  of	  the	  treatment	  scenarios	  described	  above	  were	  modeled	  using	  1,000	  stochastic	  simulations	  of	  the	  equation	  system	  by	  means	  of	  Gillespie’s	  Direct	  Method18.	  This	  approach	  converts	  the	  deterministic	  rates	  of	  the	  differential	  equation	  model	  into	  probabilities,	  and	  then	  repeatedly	  simulates	  the	  movement	  of	  individuals	  within	  the	  system	  over	  time	  based	  on	  these	  probabilities.	  The	  effect	  of	  this	  is	  two-­‐fold.	  First,	  individuals	  within	  the	  models	  are	  treated	  as	  discrete	  units	  –	  no	  fractions	  of	  patients	  exist	  in	  compartments.	  Second,	  because	  individuals	  are	  treated	  as	  discrete	  units	  and	  the	  model	  becomes	  probabilistic,	  variations	  due	  to	  random	  chance	  may	  arise.	  While	  in	  large	  population	  models	  the	  differences	  between	  these	  two	  approaches	  are	  small,	  in	  small	  populations	  this	  variability	  plays	  an	  important	  role	  in	  understanding	  the	  disease	  dynamics	  in	  the	  real	  world.	  
As	  a	  consequence	  of	  simulating	  this	  system	  as	  a	  random	  Monte	  Carlo	  process,	  it	  is	  possible	  for	  the	  patient	  population	  to	  “die	  out”	  when	  enough	  discharged	  patients	  are	  not	  replaced	  to	  reduce	  the	  patient	  population	  to	  zero,	  or	  for	  the	  patient	  population	  size	  to	  grow	  larger	  than	  12	  patients.	  These	  outcomes,	  while	  unrealistic,	  are	  important	  for	  understanding	  the	  level	  of	  possible	  variability	  inherent	  in	  the	  model	  system.	  The	  simulations	  were	  run	  over	  a	  one-­‐year	  timespan.	  
Two	  primary	  outcomes	  were	  tracked	  in	  all	  scenarios:	  the	  number	  of	  incident	  infections	  and	  the	  number	  of	  infections	  that	  develop	  into	  recurrent	  cases.	  Note	  that	  in	  many	  simulations	  we	  expected	  the	  number	  of	  recurrent	  cases	  to	  be	  higher	  than	  
	   53	  
the	  number	  of	  incident	  infections.	  The	  model	  handled	  both	  incident	  infections	  that	  arise	  in	  the	  ICU	  and	  prevalent	  infections	  on	  admission,	  both	  of	  which	  could	  develop	  into	  recurrence.	  The	  results	  of	  stochastic	  models	  are	  frequently	  non-­‐normally	  distributed,	  differences	  between	  treatment	  groups	  were	  analyzed	  with	  non-­‐parametric	  Kruskal-­‐Wallis	  tests.	  Simulations	  were	  written	  in	  Python,	  and	  all	  statistical	  analysis	  was	  performed	  in	  R.	  
Results	  
	   The	  median,	  25th	  and	  75th	  percentile	  number	  of	  recurrent	  and	  incident	  cases	  for	  all	  modeled	  scenarios	  are	  reported	  in	  Table	  5-­‐2.	  The	  baseline,	  no-­‐intervention	  model	  produced	  results	  similar	  to	  the	  known	  epidemiology	  of	  CDI.	  Infection	  rates	  were	  low,	  but	  periodic	  outbreaks	  of	  C.	  difficile	  occurred,	  as	  did	  periods	  of	  no	  infection.	  Despite	  high	  levels	  of	  patient	  colonization	  and	  sustained	  transmission	  of	  C.	  
difficile	  within	  the	  ICU,	  hand	  contamination	  of	  HCP	  was	  rare	  and	  short	  lived.	  An	  example	  showing	  the	  development	  of	  a	  typical	  simulation	  over	  time	  is	  shown	  in	  Figure	  5-­‐2.	  
The	  impact	  of	  FMT	  in	  different	  proportions	  of	  post-­‐CDI	  patients	  to	  prevent	  recurrence	  is	  shown	  in	  Figure	  5-­‐3.	  The	  treatment	  resulted	  in	  a	  statistically	  significant	  (p<0.001)	  difference	  in	  the	  number	  of	  recurrences	  among	  the	  different	  treatment	  groups.	  The	  median	  number	  of	  recurring	  cases	  ranged	  from	  2	  (Interquartile	  Range	  (IQR)=6)	  for	  no	  treatment	  to	  a	  median	  of	  0	  (IRQ=1)	  when	  100%	  of	  patients	  were	  treated.	  Treatment	  did	  not	  result	  in	  a	  significant	  difference	  in	  the	  number	  of	  incident	  infections,	  regardless	  of	  what	  proportion	  was	  treated	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(p=0.35).	  The	  median	  number	  of	  incident	  cases	  was	  0	  for	  all	  scenarios	  (IQR=1),	  save	  the	  80%	  treatment	  level	  which	  had	  an	  IQR	  of	  2.	  
The	  results	  of	  treating	  patients	  prophylactically	  after	  discontinuation	  of	  antibiotic	  therapy	  or	  PPIs	  had	  similar	  results.	  Figure	  5-­‐4	  shows	  the	  results	  of	  the	  latter	  scenario	  for	  the	  different	  proportions	  of	  treatment.	  Neither	  approach	  resulted	  in	  a	  statistically	  significant	  difference	  in	  recurrence,	  regardless	  of	  the	  proportion	  treated	  (p=0.47	  and	  0.97	  respectively);	  all	  scenarios	  had	  a	  median	  number	  of	  recurrent	  cases	  of	  2.	  
The	  difference	  in	  incident	  infections	  was	  statistically	  significant	  when	  the	  treatment	  group	  was	  limited	  to	  patients	  receiving	  only	  antibiotics	  over	  all	  levels	  of	  treatment	  (p=0.004)	  but	  not	  antibiotics,	  PPIs	  or	  both	  (p=0.09).	  In	  both	  treatment	  scenarios	  however,	  this	  difference	  did	  not	  result	  in	  tangibly	  different	  model	  outcomes	  from	  a	  clinical	  perspective.	  In	  scenarios	  treating	  only	  patients	  on	  antibiotics,	  all	  treatment	  levels	  had	  a	  median	  of	  0	  incident	  cases	  (IQR=1).	  Simulations	  with	  0%	  treatment	  did	  have	  a	  higher	  maximum	  number	  of	  incident	  cases	  (N=16)	  than	  models	  treating	  20%	  to	  100%	  of	  cases	  (N	  =10,	  13,	  11,	  10,	  14	  respectively).	  Similar	  patterns	  were	  seen	  for	  simulations	  treating	  patients	  on	  both	  antibiotics	  and	  PPIs	  (not	  shown).	  
	   Combining	  both	  prophylactic	  treatment	  and	  post-­‐infection	  treatment	  protocols	  resulted	  in	  a	  statistically	  significant	  difference	  in	  recurrent	  cases	  over	  the	  proportion	  of	  patients	  treated	  (p<0.001).	  The	  median	  number	  of	  recurring	  cases	  ranged	  from	  2	  (IQR=6)	  for	  no	  treatment	  to	  a	  median	  of	  0	  (IQR=1)	  when	  all	  patients	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were	  treated.	  This	  strategy	  also	  resulted	  in	  a	  statistically	  significant	  difference	  in	  incident	  infections	  (p=0.007),	  though	  as	  with	  the	  purely	  prophylactic	  scenarios,	  this	  difference	  did	  not	  manifest	  in	  a	  change	  in	  median	  incidence,	  as	  all	  treatment	  levels	  had	  a	  median	  number	  of	  cases	  of	  0	  (IQR=1).	  However,	  the	  no	  treatment	  scenario	  had	  a	  higher	  maximum	  number	  of	  incident	  cases	  (N=16)	  compared	  to	  treatment	  levels	  of	  20%-­‐100%	  (N=11,	  7,	  9,	  11,	  9	  respectively).	  These	  results	  are	  shown	  in	  Figure	  5-­‐5.	  
Discussion	  
Our	  unique	  study	  using	  mathematical	  modeling	  found	  that	  the	  widespread	  use	  of	  FMT	  resulted	  in	  a	  marked	  reduction	  in	  discharges	  that	  would	  go	  on	  to	  develop	  into	  recurrent	  cases.	  Importantly,	  this	  reduction	  was	  seen	  in	  all	  modeled	  scenarios	  ranging	  from	  relatively	  low	  levels	  of	  treatment	  (20%	  of	  patients)	  to	  very	  high	  levels	  of	  treatment	  (100%	  of	  patients)	  with	  no	  apparent	  threshold	  effect.	  This	  widespread	  evidence	  of	  a	  positive	  effect	  suggests	  that	  these	  results	  should	  be	  robust	  not	  only	  to	  varying	  levels	  of	  treatment,	  but	  also	  to	  lower	  levels	  of	  efficacy,	  as	  the	  two	  are	  mathematically	  equivalent.	  
	   Unsurprising,	  as	  post-­‐CDI	  treatment	  to	  prevent	  recurrent	  cases	  is	  an	  entirely	  post-­‐infection	  process,	  the	  modeled	  intervention	  had	  very	  little	  impact	  on	  incident,	  hospital-­‐acquired	  infections.	  Some	  secondary	  effects	  may	  be	  seen	  if	  fecal	  transplantation	  becomes	  a	  regularly	  used	  treatment,	  by	  way	  of	  a	  reduced	  number	  of	  recurrent	  cases	  resulting	  in	  fewer	  admissions	  with	  prevalent	  recurring	  C.	  difficile.	  Capturing	  this	  phenomenon	  would	  require	  modeling	  not	  only	  a	  single	  ward	  but	  an	  entire	  local	  healthcare	  system,	  which	  is	  beyond	  the	  scope	  of	  this	  study.	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   The	  evidence	  for	  a	  positive	  effect	  of	  using	  FMT	  after	  high-­‐risk	  medications	  to	  prevent	  incident	  infection	  is	  less	  apparent.	  While	  treating	  patients	  on	  antibiotics	  or	  both	  antibiotics	  and	  proton-­‐pump	  inhibitors	  resulted	  in	  statistically	  significant	  or	  nearly	  significant	  results	  at	  an	  alpha	  equals	  0.05	  level,	  these	  results	  appear	  to	  have	  little	  tangible	  clinical	  impact	  on	  the	  number	  of	  incident	  infections	  and	  no	  impact	  on	  the	  occurrence	  of	  recurrent	  infections.	  There	  is	  also	  very	  little	  evidence	  for	  a	  synergistic	  effect	  between	  the	  two	  treatment	  strategies.	  Scenarios	  that	  explored	  the	  use	  of	  post-­‐CDI	  and	  post-­‐high	  risk	  medication	  FMT	  simultaneously	  were	  very	  similar	  to	  that	  of	  post-­‐CDI	  FMT	  alone.	  Taken	  as	  a	  whole,	  these	  results	  indicate	  that	  routine	  use	  of	  fecal	  transplantation	  represents	  a	  promising	  tool	  to	  prevent	  complicated,	  recurring	  episodes	  of	  C.	  difficile,	  but	  techniques	  to	  recolonize	  the	  intestinal	  tract	  alone	  will	  be	  insufficient	  to	  contain	  the	  spread	  of	  C.	  difficile	  within	  a	  healthcare	  system.	  
This	  study	  is	  not	  without	  limitations.	  Many	  of	  the	  states	  within	  the	  model,	  such	  as	  whether	  or	  not	  a	  patient	  has	  come	  into	  contact	  with	  C.	  difficile,	  are	  not	  regularly	  observed	  within	  hospitals,	  and	  thus	  some	  of	  the	  outcomes	  of	  the	  model	  cannot	  be	  directly	  verified.	  As	  with	  all	  mathematical	  models,	  the	  results	  of	  the	  study	  are	  dependent	  on	  the	  assumptions	  about	  the	  natural	  history	  of	  C.	  difficile	  infection	  and	  the	  values	  of	  the	  parameters	  used.	  The	  purpose	  of	  this	  study,	  however,	  is	  not	  to	  provide	  precise	  predictions	  of	  future	  levels	  of	  infection,	  but	  rather	  to	  examine	  the	  overall	  impact	  of	  fecal	  transplantation	  as	  a	  routine	  treatment	  option	  when	  dealing	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with	  C.	  difficile.	  Within	  this	  scope,	  the	  model	  structure	  and	  parameter	  estimates	  represent	  the	  state-­‐of-­‐the-­‐art	  knowledge	  of	  in-­‐hospital	  C.	  difficile	  transmission.	  
	   This	  study	  represents,	  to	  the	  best	  of	  our	  knowledge,	  the	  first	  use	  of	  a	  mathematical	  model	  to	  quantify	  the	  potential	  effects	  of	  fecal	  transplantation	  for	  the	  treatment	  and	  prevention	  of	  CDI.	  These	  types	  of	  models	  represent	  a	  useful	  method	  for	  evaluating	  the	  potential	  impact	  of	  new	  treatment	  approaches	  in	  areas	  of	  limited	  clinical	  and	  empirical	  evidence.	  Our	  results	  suggest	  that	  routine	  intestinal	  recolonization	  is	  a	  powerful	  tool	  for	  the	  prevention	  of	  recurrent	  infection.	  When	  combined	  with	  other	  infection	  control	  measures	  such	  as	  improved	  surface	  disinfection	  and	  antibiotic	  stewardship,	  fecal	  transplant	  has	  great	  potential	  to	  produce	  a	  substantial	  reduction	  in	  the	  burden	  of	  C.	  difficile,	  especially	  in	  reducing	  highly	  morbid	  and	  difficult	  to	  manage	  recurrent	  infections.	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Figure	  5-­‐1.	  Schematic	  representation	  of	  the	  compartmental	  flow	  of	  a	  mathematical	  model	  of	  the	  use	  of	  fecal	  transplantation	  to	  prevent	  incident	  and	  recurrent	  C.	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Table	  5-­‐1.	  Parameters	  for	  a	  Mathematical	  Model	  of	  the	  Use	  of	  Fecal	  Transplantation	  to	  Prevent	  Clostridium	  difficile	  Infection	  and	  Recurrence	  
Abbreviations:	  CDI,	  C.	  difficile	  infection,	  HCP,	  Healthcare	  Personnel;	  PPI,	  Proton	  Pump	  Inhibitor;	  DICON,	  Duke	  Infection	  Control	  Outreach	  Network,	  UNC,	  University	  of	  North	  Carolina	  	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  *Assumed	  to	  be	  highly	  efficient	  based	  on	  general	  agreement	  between	  skin	  sampling	  and	  hand	  culture	  methods,	  indicating	  a	  minimal	  loss	  of	  contamination	  between	  contamination	  from	  a	  patient	  skin	  site	  to	  deposition	  on	  another	  surface.	  	  	  
Symbol	   Description	   Value	  (Units)	   Source	  
ι	   Handwashing	  Rate	   9.365	  hand	  washes	  or	  glove	  changes	  per	  hour	   61-­‐63	  
ρ	   Contact	  rate	  between	  patients	  and	  HCP	   4.244	  direct	  care	  tasks	  per	  patient	  per	  hour	   64	  
σi	   Probability	  a	  healthcare	  provider’s	  hands	  are	  contaminated	  by	  contact	  with	  a	  patient	  of	  type	  i	   Low	  Risk:	  0.35,	  High	  Risk:	  0.35	  Active	  Infections:	  0.50	   33,52,59,65,66	  
Ψ	   Probability	  of	  transmission	  from	  a	  contaminated	  HCP	  hands	  to	  a	  uncontaminated	  patient’s	  skin	   0.90*	   33	  
θi 	   Discharge	  rate	  for	  an	  uninfected	  patient	  of	  type	  i	   High	  Risk:	  1/	  12.006	  days	  Low	  Risk:	  1/	  3.318	  days	   UNC	  Healthcare	  Billing	  Data	  
ζ	   Hourly	  probability	  of	  death	  for	  a	  patient	  with	  an	  active	  C.	  difficile	  infection	   0.000625	   DICON	  Cohort	  Data	  
γ	   Hourly	  probability	  of	  discharge	  for	  a	  patient	  with	  an	  active	  C.	  difficile	  infection	   0.00188	   DICON	  Cohort	  Data	  
νi	   Proportion	  of	  admitted	  patients	  who	  are	  of	  patient	  type	  i	   CP:	  0.00447,	  CA:	  0.0155,	  UP:	  0.209,	  UA:	  0.727,	  D:	  0.044	   UNC	  Healthcare	  Billing	  Data,	  35,37	  
κ	   Hazard	  of	  developing	  CDI	  in	  low-­‐risk,	  contaminated	  patients	   0.000268	   DICON	  Surveillance	  Data	  
τ	   Relative	  Risk	  of	  developing	  CDI	  due	  to	  high-­‐risk	  treatment	   3.37	   53,59,67	  
Φ	   Probability	  of	  receiving	  post-­‐treatment	  fecal	  transplant	  to	  prevent	  incident	  infection	  or	  recurrence	   Antibiotics-­‐only:	  	  0.0011	  Antibiotics	  &	  PPIs:	  0.00169	   UNC	  Healthcare	  Billing	  Data,	  68-­‐71	  
χ	   Percent	  of	  eligible	  patients	  receiving	  fecal	  transplant	   0	  –	  100	  (varies	  by	  scenario)	   	  
ω	   Probability	  of	  a	  discharged	  patient	  developing	  recurrence	   0.30	   54	  
η	   Probability	  of	  fecal	  transplant	  in	  moving	  patient	  to	  low-­‐risk	  category	   0.938	   55	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Table	  5-­‐2.	  Patient	  Outcomes	  from	  a	  Mathematical	  Model	  of	  the	  Use	  of	  Fecal	  Transplantation	  to	  Prevent	  Clostridium	  difficile	  Infection	  and	  Recurrence	  in	  a	  Simulated	  12-­‐bed	  ICU	  Over	  One	  Year.	  
Scenario	   Percent	  
Treated	  
Median	  Recurrence	  	  
(25th	  &	  75th	  
Percentiles)	  
p-­‐value*	   Median	  Incidence	  	  
(25th	  &	  75th	  
Percentiles)	  
p-­‐value*	  
Baseline	   0%	   2	  (0,6)	   	   0	  (0,1)	   	  	   	   	   	   	   	  
Post-­‐Infection	   20%	   1	  (0,4.25)	   <	  0.001	   0	  (0,1)	   0.35	  	   40%	   1	  (0,4)	   	   0	  (0,1)	   	  	   60%	   1(0,3)	   	   0	  (0,1)	   	  	   80%	   0	  (0,2)	   	   0	  (0,2)	   	  	   100%	   0	  (0,1)	   	   0	  (0,1)	   	  	   	   	   	   	   	  
Prophylactic	  	   20%	   2	  (0,5)	   0.47	   0	  (0,1)	   0.004	  
(Antibiotics)	   40%	   2	  (0,6)	   	   0	  (0,1)	   	  	   60%	   2	  (0,5)	   	   0	  (0,1)	   	  	   80%	   2	  (0,6)	   	   0	  (0,1)	   	  	   100%	   1	  (0,5)	   	   0	  (0,1)	   	  	   	   	   	   	   	  
Prophylactic	   20%	   2	  (0,6)	   0.97	   0	  (0,1)	   0.09	  
(Antibiotics	  and	   40%	   2	  (0,6)	   	   0	  (0,1)	   	  
PPIs)	   60%	   2	  (0,6)	   	   0	  (0,1)	   	  	   80%	   2	  (0,7)	   	   0	  (0,1)	   	  	   100%	   2	  (0,6)	   	   0	  (0,1)	   	  	   	   	   	   	   	  
Combined	   20%	   1	  (0,6)	   <	  0.001	   0	  (0,1)	   0.007	  	   40%	   1	  (0,5)	   	   0	  (0,1)	   	  	   60%	   1	  (0,3)	   	   0	  (0,1)	   	  	   80%	   0	  (0,2)	   	   0	  (0,1)	   	  	   100%	   0	  (0,1)	   	   0	  (0,1)	   	  Abbreviations:	  PPI,	  Proton	  Pump	  Inhibitor	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *Kruskal-­‐Wallis	  one-­‐way	  analysis	  of	  variance	  test	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Figure	  5-­‐2.	  A	  single	  stochastic	  realization	  of	  a	  mathematical	  model	  of	  the	  use	  of	  fecal	  transplantation	  to	  prevent	  incident	  and	  recurrent	  C.	  difficile.	  The	  top	  panel	  shows	  the	  level	  of	  hand	  contamination	  in	  healthcare	  workers	  over	  a	  24	  hour	  period,	  while	  the	  bottom	  two	  panels	  depict	  the	  number	  of	  patients	  and	  their	  current	  health	  state	  over	  a	  one-­‐year	  period.	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Chapter	  6:	  Conclusions	  and	  Future	  Directions	  	  
This	  dissertation	  has	  explored	  the	  use	  of	  mathematical	  models	  to	  study	  the	  transmission	  of	  C.	  difficile	  in	  healthcare	  settings	  by	  combining	  mathematical	  and	  computational	  methods	  with	  modern	  observational	  epidemiology.	  The	  two	  should	  be	  thought	  of	  as	  mutually	  reinforcing	  disciplines,	  interacting	  with	  one	  another	  in	  a	  continual	  cycle	  of	  research,	  rather	  than	  viewing	  one	  as	  a	  lesser	  substitute	  when	  the	  other	  is	  untenable	  for	  a	  specific	  question.	  Mathematical	  models	  help	  organize	  and	  formalize	  the	  present	  state	  of	  knowledge	  about	  a	  disease	  system,	  discovering	  areas	  where	  there	  is	  currently	  an	  absence	  of	  empirical	  data.	  Empirical	  studies,	  in	  turn,	  provide	  unbiased	  parameters	  for	  mathematical	  models	  that	  can	  then	  be	  used	  to	  extend	  the	  results	  of	  those	  same	  studies	  into	  new	  and	  unexplored	  areas.	  
To	  accomplish	  this,	  parameters	  for	  a	  mathematical	  model	  were	  estimated	  using	  parametric	  mixture	  models	  from	  a	  cohort	  of	  CDI	  cases	  from	  the	  DICON	  hospital	  network	  (Aim	  1a)	  and	  parametric	  accelerated	  failure	  time	  models	  from	  inpatient	  billing	  data	  from	  UNC	  Healthcare	  (Aim	  1b),	  as	  well	  as	  estimates	  from	  the	  literature	  and	  fitting	  a	  deterministic	  compartmental	  model	  to	  DICON	  surveillance	  data	  (Aim	  2a).	  From	  these	  parameters,	  identically	  formulated	  deterministic	  and	  stochastic	  compartmental	  models	  (Aim	  2b)	  were	  used	  to	  examine	  the	  potential	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impact	  of	  FMT	  as	  a	  routine	  treatment	  for	  the	  prevention	  of	  either	  incident	  or	  recurrent	  CDI	  (Aim	  3).	  
Key	  Findings	  
Parametric	  Mixture	  Models	  for	  CDI	  Outcomes	  
	   The	  parametric	  mixture	  models	  used	  in	  Chapter	  4	  represent	  a	  method	  for	  handling	  mutually	  exclusive	  competing	  risks	  that	  disentangles	  the	  time	  until	  an	  event	  occurs	  and	  the	  frequency	  with	  which	  it	  occurs.	  Using	  a	  cohort	  of	  609	  incident,	  healthcare-­‐associated	  CDI	  cases,	  we	  estimate	  that	  the	  all-­‐cause	  case	  mortality	  rate	  for	  ICU	  patients	  was	  28%	  for	  cases	  in	  the	  ICU,	  compared	  to	  10%	  for	  cases	  outside	  the	  ICU	  (OR	  =	  3.38	  (95%	  CI:	  1.84,	  6.19)).	  Compared	  to	  patients	  not	  in	  the	  ICU,	  CDI	  patients	  in	  the	  ICU	  experienced	  longer	  times	  until	  death	  (RTD	  =	  1.97	  (95%	  CI:	  0.96,	  4.01))	  and	  longer	  times	  until	  discharge	  (RTN	  =	  1.88	  (95%	  CI:	  1.40,	  2.51).	  This	  is	  in	  contrast	  to	  the	  conventional	  cause-­‐specific	  approach	  to	  modeling	  competing	  risks,	  which	  overestimated	  the	  difference	  in	  time	  until	  discharge	  (RTN	  =	  2.30	  (95%	  CI:	  1.66,	  3.18))	  and	  not	  only	  underestimated	  the	  difference	  in	  time	  until	  death,	  but	  estimated	  it	  on	  the	  other	  side	  of	  the	  null,	  suggesting	  ICU	  patients	  had	  a	  shorter	  –	  though	  not	  statistically	  significant	  –	  time	  until	  death	  (RTD	  =	  0.65	  (95%	  CI:	  0.36,	  1.17)).	  
	   These	  results	  have	  importance	  both	  from	  an	  infection	  control	  and	  epidemiological	  methods	  standpoint.	  Patients	  within	  the	  ICU	  experience	  longer	  times	  until	  both	  death	  and	  discharge	  and	  experience	  a	  higher	  burden	  of	  mortality.	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As	  a	  result,	  despite	  their	  relatively	  small	  numbers,	  they	  represent	  a	  population	  of	  concern	  for	  the	  prevention	  of	  CDI,	  despite	  CDI	  being	  often	  thought	  of	  as	  a	  hospital-­‐wide	  problem.	  Beyond	  the	  higher	  frequency	  of	  negative	  outcomes,	  patients	  who	  remain	  in	  the	  hospital	  longer	  have	  a	  greater	  opportunity	  to	  shed	  infectious	  material	  into	  the	  environment	  and	  to	  contaminate	  the	  hands	  of	  HCP	  that	  care	  for	  them.	  From	  a	  methodological	  perspective,	  these	  findings	  suggest	  that	  in	  some	  circumstances	  cause-­‐specific	  models,	  which	  conflate	  the	  time	  until	  an	  event	  occurs	  and	  frequency	  with	  which	  it	  occurs	  may	  lead	  to	  errant	  estimates.	  
Mathematical	  Models	  of	  Routine	  Fecal	  Transplantation	  
	   Using	  the	  parameters	  obtained	  from	  the	  DICON	  cohort	  and	  surveillance	  data,	  as	  well	  as	  UNC	  Healthcare	  billing	  data	  and	  estimates	  from	  the	  literature,	  a	  compartmental	  model	  of	  C.	  difficile	  transmission	  within	  an	  ICU	  was	  developed.	  This	  model	  explored	  the	  impact	  of	  using	  fecal	  transplantation	  to	  restore	  the	  intestinal	  flora	  of	  patients	  who	  had	  undergone	  flora-­‐disrupting	  treatments	  involving	  antibiotics	  or	  proton	  pump	  inhibitors.	  Two	  different	  potential	  interventions	  were	  simulated:	  the	  regular	  use	  of	  FMT	  to	  treat	  CDI	  cases	  to	  prevent	  recurrence,	  and	  the	  use	  of	  FMT	  as	  a	  post-­‐treatment	  prophylactic	  to	  prevent	  the	  development	  of	  CDI	  for	  patients	  at	  the	  end	  of	  course	  of	  antibiotics	  or	  PPIs.	  Over	  a	  number	  of	  modeled	  scenarios,	  the	  model	  consistently	  found	  that	  post-­‐CDI	  fecal	  transplantation	  has	  a	  positive,	  statistically	  significant	  impact	  on	  the	  number	  of	  recurrences	  but	  no	  impact	  on	  incident	  cases.	  The	  evidence	  for	  the	  use	  of	  FMT	  as	  a	  prophylactic	  measure	  to	  prevent	  the	  development	  of	  CDI	  is	  somewhat	  less	  definitive.	  Prophylactic	  treatment	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did	  not	  result	  in	  a	  decrease	  in	  recurrence,	  and	  while	  it	  did	  result	  in	  a	  borderline	  significant	  decrease	  in	  incident	  cases,	  this	  difference	  did	  not	  manifest	  in	  a	  decrease	  that	  would	  meaningfully	  impact	  clinical	  care.	  
Strengths	  and	  Limitations	  
	   This	  dissertation	  represents	  a	  fusion	  of	  observational	  epidemiology	  and	  mathematical	  modeling,	  and	  is	  the	  first	  study	  we	  are	  aware	  of	  which	  uses	  these	  two	  techniques	  to	  examine	  the	  use	  of	  routine	  fecal	  transplantation	  for	  the	  prevention	  of	  incident	  or	  recurrent	  CDI.	  It	  provides	  a	  “best	  of	  both	  worlds”	  approach,	  using	  modern	  observational	  methods	  to	  provide	  robust,	  unbiased	  parameter	  estimates	  for	  the	  mathematical	  model	  and	  using	  the	  mathematical	  model	  in	  turn	  to	  extend	  the	  results	  of	  the	  limited	  observational	  evidence	  available	  for	  the	  clinical	  impact	  of	  fecal	  transplantation	  and	  to	  suggest	  new	  directions	  for	  empirical	  research.	  
	   As	  with	  all	  studies,	  this	  dissertation	  has	  limitations.	  While	  extensive	  effort	  went	  in	  to	  insuring	  the	  parameter	  estimates	  obtained	  from	  observation	  data	  were	  unbiased,	  there	  is	  the	  potential	  for	  residual	  confounding	  and	  unknown	  misclassification	  is	  ever	  present.	  Additionally,	  because	  of	  the	  nature	  of	  C.	  difficile	  as	  a	  healthcare-­‐associated	  infection	  for	  which	  hospitals	  are	  not	  reimbursed	  by	  insurance	  or	  CMS,	  there	  is	  no	  single	  source	  of	  data	  that	  follows	  the	  whole	  cohort	  of	  hospital	  inpatients	  from	  admission	  to	  discharge.	  As	  such,	  a	  working	  picture	  of	  an	  intensive	  care	  unit	  must	  be	  assembled	  from	  disparate	  sources	  and	  then	  be	  assumed	  to	  be	  capable	  of	  being	  meaningfully	  melded	  together	  into	  a	  single	  coherent	  model.	  The	  similarity	  of	  the	  two	  sources	  of	  data,	  both	  major	  healthcare	  systems	  in	  the	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Southeastern	  USA	  over	  the	  same	  time	  period	  is	  intended	  to	  minimize	  the	  effect	  of	  this	  merging	  of	  data,	  but	  it	  is	  possible	  that	  the	  parameters	  arising	  from	  one	  data	  source	  reflect	  a	  different	  local	  “reality”	  of	  C.	  difficile	  transmission	  compared	  to	  those	  arising	  from	  the	  other.	  Finally,	  the	  mathematical	  model	  used	  in	  this	  dissertation	  is	  subject	  to	  the	  assumptions	  outlined	  in	  Chapter	  2	  and	  is	  only	  valid	  insofar	  as	  those	  assumptions	  are	  not	  violated.	  These	  limitations	  are	  however,	  as	  much	  a	  call	  for	  further	  research	  as	  they	  are	  caveats	  about	  the	  present	  findings.	  This	  dissertation	  reflects	  the	  most	  current	  knowledge	  of	  C.	  difficile,	  derived	  from	  an	  extensive	  review	  of	  both	  the	  mathematical	  modeling	  and	  clinical	  literatures,	  as	  well	  as	  the	  analysis	  of	  several	  datasets	  using	  modern	  epidemiological	  methods.	  The	  modeling	  results	  within	  it	  are	  not	  meant	  to	  be	  exact	  predictions	  of	  case	  counts,	  but	  rather	  a	  first	  attempt	  at	  quantifying	  the	  impact	  of	  adopting	  a	  novel	  treatment	  as	  the	  standard	  of	  care	  for	  C.	  difficile,	  and	  within	  this	  more	  limited	  intention,	  are	  as	  robust	  as	  possible.	  
Future	  Research	  
	   Several	  avenues	  of	  continued	  research	  present	  themselves	  based	  on	  the	  results	  of	  this	  dissertation.	  Many	  of	  the	  limitations	  of	  the	  current	  mathematical	  model	  lie	  in	  the	  assumptions	  arising	  from	  its	  compartmental	  model	  formulation.	  As	  much	  as	  this	  is	  a	  challenge	  to	  the	  present	  model,	  it	  is	  an	  opportunity	  for	  future	  research,	  as	  the	  findings	  of	  this	  model	  can	  evaluated	  using	  more	  sophisticated	  models	  that	  reflect	  a	  more	  realistic	  process	  of	  mixing	  between	  patients	  and	  HCPs	  as	  well	  as	  environmental	  contamination.	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The	  purpose	  of	  such	  an	  evaluation	  is	  two-­‐fold.	  First,	  it	  allows	  for	  a	  progressively	  more	  robust	  examination	  of	  a	  clinically	  relevant	  problem,	  providing	  better	  and	  more	  realistic	  predictions	  of	  the	  impact	  of	  fecal	  transplantation	  as	  a	  routine	  therapeutic	  option.	  Second,	  the	  sequential	  examination	  of	  the	  same	  research	  question,	  using	  largely	  the	  same	  parameters	  but	  with	  progressively	  more	  sophisticated	  model	  forms	  represents	  a	  relatively	  poorly	  explored	  area	  of	  research:	  sensitivity	  analysis	  not	  of	  a	  particular	  parameter	  or	  parameters,	  but	  of	  model	  structure	  as	  a	  whole.	  
Mathematical	  models	  are	  descriptions	  of	  the	  dynamics	  of	  a	  system,	  a	  representation	  of	  how	  we	  believe	  an	  infection	  process	  to	  work.	  Even	  with	  perfect	  parameter	  values,	  the	  choices	  a	  researcher	  makes	  in	  how	  to	  represent	  this	  system	  have	  a	  major	  impact	  on	  the	  outcomes	  of	  the	  model.	  Despite	  this,	  much	  of	  the	  current	  focus	  in	  the	  sensitivity	  analysis	  of	  mathematical	  models	  is	  focused	  on	  the	  variation	  of	  particular	  parameters	  while	  keeping	  the	  more	  fundamental	  structure	  of	  the	  model	  constant.	  Extending	  sensitivity	  analysis	  to	  questions	  of	  model	  structure	  would	  benefit	  the	  field	  not	  only	  by	  evaluating	  the	  robustness	  of	  certain	  results	  to	  changes	  in	  model	  type,	  but	  also	  in	  an	  increased	  understanding	  of	  what	  types	  of	  questions	  require	  more	  sophisticated	  model	  types	  such	  as	  network	  or	  agent-­‐based	  models	  and	  what	  types	  are	  adequately	  addressed	  with	  more	  approachable	  implementations.	  
Finally,	  mathematical	  models	  are	  flexible	  tools,	  and	  even	  for	  a	  system	  as	  well	  studied	  as	  C.	  difficile	  there	  are	  a	  wealth	  of	  questions	  that	  lend	  themselves	  well	  to	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modeling	  and	  can	  be	  examined	  with	  small	  modifications	  to	  the	  same	  basic	  model	  structure.	  Some	  examples	  of	  these	  questions	  might	  be	  the	  potential	  impact	  of	  new	  surface	  decontamination	  procedures,	  the	  role	  of	  staffing	  levels	  and	  ICU	  design	  (closed	  vs.	  open	  ICUs),	  and	  novel	  therapies	  for	  the	  treatment	  or	  prevention	  of	  C.	  
difficile,	  among	  others.	  As	  many	  of	  these	  questions	  involve	  the	  dynamic	  interaction	  of	  patients,	  HCP	  and	  the	  environment	  that	  elude	  statistical	  techniques,	  mathematical	  models	  will	  play	  a	  critical	  role	  in	  eventually	  understanding	  their	  respective	  impact	  on	  the	  spread	  of	  a	  pathogen	  of	  serious	  and	  growing	  public	  health	  concern.	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Appendix:	  Model	  Parameterization	  What	  follows	  is	  a	  more	  detailed	  look	  at	  the	  parameter	  values	  used	  in	  the	  mathematical	  model	  described	  in	  Chapter	  5.	  Such	  a	  description	  would	  distract	  from	  the	  overall	  message	  of	  that	  chapter,	  but	  may	  be	  of	  interest	  to	  the	  reader.	  
Discharge	  Rates	  
Rates	  of	  death	  and	  discharge	  for	  CDI	  cases	  were	  obtained	  using	  estimates	  from	  Chapter	  4.	  The	  length	  of	  stay	  for	  non-­‐CDI	  patients	  was	  determined	  using	  parametric	  survival	  models	  using	  a	  technique	  similar	  to	  that	  discussed	  in	  Chapter	  4,	  but	  for	  a	  single	  outcome	  using	  the	  subsample	  of	  ICU	  patients	  from	  the	  UNC	  Healthcare	  inpatient	  billing	  data	  set.	  By	  default,	  the	  rates	  in	  a	  Gillespie	  Direct	  Method-­‐based	  stochastic	  model	  result	  in	  exponentially	  distributed	  waiting	  times,	  with	  a	  single	  rate	  parameter	  λ	  equal	  to	  the	  reciprocal	  of	  the	  average	  time	  until	  death,	  discharge,	  etc.	  An	  alternate	  formulation	  however,	  using	  n	  compartments	  for	  each	  transition	  between	  health	  states	  allows	  the	  waiting	  times	  to	  take	  the	  form	  of	  a	  gamma	  distribution	  with	  the	  shape	  parameter	  κ	  =	  n	  and	  a	  scale	  parameter	  θ	  =	  the	  average	  time	  until	  death,	  discharge,	  etc.	  75.	  Because	  many	  of	  best	  fitting	  parametric	  survival	  models	  were	  not	  exponential,	  but	  rather	  log-­‐normally	  distributed,	  it	  may	  be	  necessary	  to	  use	  the	  more	  flexible	  gamma	  distribution	  to	  provide	  simulated	  waiting	  times	  comparable	  to	  those	  obtained	  from	  data.	  However,	  as	  a	  gamma	  distribution	  is	  not	  a	  survival	  distribution	  generally	  supported	  in	  available	  software,	  a	  gamma	  distribution	  cannot	  be	  fit	  directly.	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Instead,	  a	  gamma	  distribution	  approximating	  a	  log	  normal	  distribution	  with	  parameters	  μ	  and	  σ	  was	  obtained	  by	  minimizing	  the	  Kullback-­‐Leibler	  divergence,	  an	  information	  theoretic	  measure	  of	  the	  difference	  between	  two	  probability	  distributions	  76.	  Each	  log-­‐normal	  survival	  curve	  obtained	  from	  the	  accelerated	  failure	  time	  models	  was	  approximated	  by	  a	  gamma	  distribution	  meant	  to	  minimize	  K-­‐L	  divergence,	  with	  κ	  constrained	  to	  be	  a	  positive,	  non-­‐zero	  integer	  (necessary	  for	  implementation	  as	  a	  series	  of	  compartments).	  Weibull	  distributed	  survival	  times	  were	  refit	  as	  exponentially	  distributed	  survival	  times	  for	  the	  purposes	  of	  model	  parameterization.	  Comparisons	  of	  the	  empirically	  estimated	  density	  functions	  and	  survival	  curves	  to	  their	  approximated	  counterparts	  are	  shown	  in	  Figures	  A1	  –	  A4.	  All	  approximated	  gamma	  distributions	  had	  κ	  =1,	  which	  reduces	  to	  an	  exponential	  distribution,	  confirming	  the	  default	  assumptions	  of	  the	  Gillespie	  implementation	  as	  justified.	  
The	  estimated	  length	  of	  stay	  for	  high	  risk,	  non-­‐CDI	  patients	  was	  12.006	  days,	  while	  for	  low-­‐risk	  patients	  it	  was	  3.318	  days,	  which	  translate	  to	  hourly	  rates	  of	  0.00347	  and	  0.0126	  respectively.	  The	  rate	  of	  discharge	  for	  patients	  with	  CDI	  is	  a	  combination	  of	  the	  probability	  of	  being	  safely	  discharged	  from	  the	  hospital	  and	  the	  time	  it	  takes	  to	  be	  discharged.	  Based	  on	  the	  estimates	  in	  Chapter	  4,	  it	  is	  estimated	  that	  patients	  have	  a	  72.15%	  chance	  of	  being	  discharged,	  with	  a	  mean	  time	  until	  discharge	  of	  15.768	  days.	  Similarly,	  patients	  with	  CDI	  have	  a	  27.85%	  chance	  of	  dying	  while	  in	  the	  hospital,	  with	  a	  mean	  time	  until	  death	  of	  18.66	  days.	  Combining	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the	  two,	  we	  obtain	  an	  hourly	  probability	  of	  death	  for	  CDI	  patients	  of	  0.000625	  and	  an	  hourly	  probability	  of	  discharge	  of	  0.00188.	  
Contact	  Rate	  
	   The	  contact	  rate	  between	  patients	  and	  HCP	  was	  estimated	  from	  studies	  using	  the	  ‘Work	  Observation	  Method	  by	  Activity	  Timing’	  (WOMBAT)	  method.	  These	  studies	  can	  estimate	  the	  number	  of	  patient	  care	  tasks	  a	  HCP	  engages	  in	  per	  hour	  that	  involve	  direct	  contact	  with	  the	  patient	  or	  their	  immediate	  environment.	  The	  estimates	  used	  in	  the	  model	  described	  in	  Chapter	  5	  are	  obtained	  from	  a	  study	  of	  the	  time	  use	  patterns	  of	  100	  Canadian	  critical	  care	  HCP	  64.	  Based	  on	  additional	  data	  provided	  by	  Ballermann	  and	  colleagues,	  this	  study	  estimates	  that	  nurses	  perform	  11.92	  direct	  care	  tasks	  per	  hour	  and	  doctors	  perform	  3.253	  direct	  care	  tasks	  per	  hour.	  Combined	  with	  the	  staffing	  levels	  described	  in	  the	  model	  and	  assuming	  random	  mixing	  and	  a	  uniform	  care	  load	  between	  patients,	  this	  results	  in	  4.244	  direct	  care	  tasks	  per	  patient	  per	  hour.	  As	  these	  tasks	  include	  all	  tasks	  related	  to	  direct	  patient	  care,	  including	  those	  that	  do	  not	  involve	  touching	  the	  patient,	  they	  represent	  an	  attempt	  to	  capture	  HCP	  interaction	  with	  the	  potentially	  contaminated	  physical	  environment	  as	  well,	  within	  the	  limitations	  of	  a	  compartmental	  model.	  
Handwashing	  Rate	  
	   The	  rate	  of	  hand	  washing	  is	  a	  composite	  of	  the	  number	  of	  times	  a	  hand	  washing	  opportunity	  presents	  itself	  to	  a	  HCP	  (after	  all	  direct	  care	  tasks	  involving	  the	  patient	  or	  their	  environment),	  a	  rate	  of	  compliance,	  and	  a	  rate	  at	  which	  washing	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ones	  hands	  successful	  rids	  them	  of	  C.	  difficile	  contamination.	  The	  first	  two	  are	  obtained	  from	  the	  per	  HCP	  contact	  rate	  discussed	  above	  and	  a	  study	  of	  hand	  hygiene	  compliance	  within	  Duke	  Hospital61.	  
	   Typically	  in	  studies	  of	  the	  efficacy	  of	  a	  cleaning	  product	  against	  microbial	  contamination	  (such	  as	  hand	  washing	  agents),	  the	  results	  are	  reported	  in	  terms	  of	  a	  log10	  reduction	  in	  overall	  colony	  forming	  units	  (CFU)	  between	  the	  pre-­‐wash	  and	  post-­‐wash	  surfaces.	  Based	  on	  estimates	  of	  the	  efficacy	  of	  the	  mechanical	  agitation	  from	  a	  water-­‐only	  wash	  (0.76	  log10	  reduction)	  (Edmonds	  et	  al.,	  In	  Press),	  along	  with	  one	  for	  soap	  that	  had	  already	  been	  previously	  adjusted	  for	  the	  effect	  of	  water	  to	  obtain	  the	  reduction	  due	  solely	  to	  the	  introduction	  of	  soap	  (0.90	  log10	  reduction)62	  we	  obtain	  a	  combined	  1.66	  log10	  reduction	  in	  bacterial	  load.	  For	  models	  directly	  modeling	  the	  surface,	  this	  reduction	  estimate	  can	  be	  used	  in	  this	  form.	  However,	  for	  the	  compartmental	  models	  discussed	  in	  Chapter	  5,	  this	  estimate	  must	  be	  converted	  to	  a	  percent-­‐efficacy.	  
	   Based	  on	  an	  initial	  estimated	  bacterial	  load	  of	  3.20	  log10	  CFU	  on	  worker	  hands,	  the	  corresponding	  1.66	  log10	  reduction	  results	  in	  ~1.54	  log10	  CFU	  remaining,	  a	  97.8%	  reduction	  in	  the	  overall	  number	  of	  CFUs.	  This	  conversion	  makes	  the	  assumption	  that	  bacterial	  load	  is	  independent	  of	  the	  probability	  of	  infection	  –	  that	  is	  that	  an	  HCP’s	  hands	  are	  either	  clean	  or	  not,	  and	  that	  the	  corresponding	  reduction	  in	  bacterial	  load	  translates	  well	  to	  a	  probability	  that	  a	  HCP’s	  hands	  are	  below	  the	  contamination	  level	  necessary	  for	  efficient	  transmission.	  As	  there	  is	  little	  evidence	  regarding	  the	  infectious	  dose	  of	  C.	  difficile,	  the	  accuracy	  of	  this	  assumption	  is	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difficult	  to	  verify.	  However,	  the	  generally	  accepted	  efficacy	  of	  soap	  and	  water	  washes	  as	  the	  primary	  means	  of	  hand	  decontamination	  in	  the	  case	  of	  C.	  difficile	  lends	  some	  credence	  to	  the	  high	  efficacy	  estimate	  produced	  with	  this	  method,	  and	  the	  influence	  of	  this	  assumption	  on	  the	  model’s	  results	  is	  straightforward	  to	  examine	  using	  sensitivity	  analysis.	  
Probability	  of	  contamination	  of	  staff	  hands	  by	  colonized	  patient	  of	  type	  i	  
	   There	  is	  ample	  evidence	  that	  C.	  difficile	  can	  be	  found	  contaminating	  the	  hands	  of	  HCP	  after	  contact	  with	  a	  colonized	  or	  infected	  patients	  or	  the	  surrounding	  environment.	  A	  number	  of	  studies	  performed	  by	  Donskey	  and	  colleagues	  have	  directly	  examined	  the	  rate	  of	  acquisition	  of	  C.	  difficile	  spores	  on	  HCP	  hands	  after	  contact	  with	  contaminated	  skin	  sites33,52,65,66.	  While	  relatively	  small	  studies,	  they	  consistently	  report	  a	  ~50%	  contamination	  rate	  on	  gloved	  hands	  after	  contact	  with	  patients	  with	  active	  CDI.	  The	  estimation	  of	  the	  contamination	  rate	  for	  asymptomatic	  carrier	  patients	  is	  somewhat	  more	  difficult.	  In	  a	  study	  comparing	  asymptomatic	  carriers	  to	  patients	  with	  active	  CDI,	  Riggs	  et	  al.33	  report	  a	  skin	  contamination	  rate	  by	  swabbing	  sample	  sites	  of	  61%	  vs.	  78%.	  Based	  on	  the	  finding	  from	  the	  same	  paper	  that	  57%	  of	  the	  patients	  with	  contaminated	  skin	  sites	  passed	  that	  contamination	  onto	  gloved	  hands,	  we	  can	  estimate	  a	  35%	  chance	  of	  hand	  contamination	  on	  gloved	  hands	  from	  touching	  the	  skin	  of	  an	  asymptomatic	  carrier.	  No	  data	  could	  be	  found	  examining	  the	  contamination	  rates	  for	  asymptomatic	  carriers	  with	  high	  risk	  factors	  for	  developing	  CDI	  such	  as	  exposure	  to	  antibiotics	  or	  PPIs,	  and	  as	  such	  both	  types	  of	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patient,	  once	  colonized,	  are	  assumed	  to	  be	  equally	  capable	  of	  shedding	  spores	  onto	  their	  skin	  and	  the	  surrounding	  environment.	  
Probability	  of	  contamination	  of	  staff	  hands	  by	  colonized	  patient	  of	  type	  i	  
	   In	  contrast	  to	  the	  probability	  that	  a	  patient	  shedding	  C.	  difficile	  spores	  contaminates	  a	  HCP’s	  hands,	  the	  probability	  that	  contact	  with	  a	  contaminated	  HCP	  results	  in	  the	  colonization	  of	  a	  previously	  colonized	  patient	  is	  less	  well	  studied.	  Generally	  speaking	  however,	  it	  appears	  from	  studies	  estimating	  the	  bacterial	  burden	  arising	  from	  touching	  a	  shedding	  patient’s	  skin	  by	  pressing	  a	  gloved	  hand	  first	  to	  the	  patient	  and	  then	  to	  a	  culture	  plate33	  that	  gloved	  hands	  are	  a	  very	  efficient	  medium	  for	  passing	  C.	  difficile	  from	  one	  receptive	  surface	  to	  the	  next,	  and	  thus	  we	  assume	  at	  least	  transient	  skin	  colonization	  to	  be	  very	  likely	  when	  a	  contaminated	  HCP	  comes	  in	  contact	  with	  an	  uncolonized	  patient.	  
Duration	  of	  High	  Risk	  Treatment	  
The	  duration	  of	  treatment	  for	  patients	  on	  fluoroquinolones	  was	  assumed	  to	  be	  7	  days,	  in	  line	  with	  treatment	  guidelines	  for	  a	  number	  of	  different	  potential	  diseases,	  including	  skin	  and	  soft	  tissue	  infections,	  sexually	  transmitted	  infections	  and	  community-­‐acquired	  pneumonias68-­‐70,77.	  	  	  
The	  duration	  of	  treatment	  for	  the	  use	  of	  PPIs	  for	  gastric	  acid	  suppression	  is	  a	  somewhat	  more	  challenging	  task	  –	  treatment	  for	  various	  diseases	  using	  PPIs	  range	  from	  a	  single	  dose	  to	  multiple	  months	  or	  years	  of	  intermittent	  use.	  The	  duration	  of	  treatment	  with	  PPIs	  was	  assumed	  to	  be	  4	  weeks	  –	  the	  minimum	  length	  of	  treatment	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for	  a	  number	  of	  diseases	  including	  gastroesophageal	  reflux	  disease,	  the	  healing	  of	  duodenal	  ulcers	  and	  NSAID-­‐related	  gastric	  ulcers,	  although	  twice	  as	  long	  as	  the	  maximum	  recommended	  course	  for	  the	  eradication	  of	  H.	  pylori	  in	  conjunction	  with	  a	  course	  of	  antibiotics71,78-­‐80.	  Note	  that	  this	  time	  is	  considerably	  higher	  than	  the	  average	  length	  of	  stay	  for	  patients,	  hence	  the	  assumption	  within	  the	  model	  that,	  when	  combined	  with	  the	  time	  it	  would	  take	  for	  intestinal	  flora	  to	  recover,	  that	  once	  a	  patient’s	  flora	  have	  been	  disrupted,	  they	  remain	  disrupted	  for	  the	  duration	  of	  their	  stay.	  However,	  it	  is	  still	  important	  to	  estimate	  this	  parameter,	  as	  it	  is	  used	  in	  several	  of	  the	  fecal	  transplantation	  scenarios	  –	  patients	  are	  treated	  prophylactically	  immediately	  after	  the	  conclusion	  of	  their	  course	  of	  antibiotics	  or	  PPIs.	  	  
To	  reflect	  the	  mix	  of	  patients	  taking	  one	  or	  both	  drugs,	  the	  overall	  duration	  of	  treatment	  is	  the	  weighted	  average	  of	  the	  two	  drug-­‐specific	  treatment	  durations.	  Patients	  being	  treated	  with	  both	  types	  of	  drugs	  were	  assumed	  to	  be	  in	  the	  high-­‐risk	  category	  for	  the	  longer	  of	  the	  two	  treatments	  (i.e.	  patients	  on	  both	  a	  fluoroquinolone	  and	  a	  PPI	  are	  assumed	  to	  be	  in	  the	  high	  risk	  category	  for	  4	  weeks).	  Within	  the	  ICU	  patient	  population	  in	  the	  UNC	  Healthcare	  inpatient,	  14.38%	  of	  patients	  had	  an	  order	  for	  a	  fluoroquinolone	  drug	  alone,	  29.20%	  for	  a	  PPI	  alone	  and	  34.07%	  for	  the	  two	  in	  combination.	  Using	  the	  treatment	  durations	  above,	  we	  thus	  obtain	  a	  weighted	  average	  of	  high-­‐risk	  treatment	  duration	  of	  24.66	  days.	  
Proportion	  of	  Admitted	  Patients	  Who	  Are	  Of	  Patient	  Type	  i	  
	   The	  proportion	  of	  patients	  admitted	  into	  the	  D	  compartment,	  representing	  patients	  with	  CDI	  was	  determined	  to	  be	  0.044,	  based	  on	  the	  proportion	  of	  patients	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in	  the	  ICU	  who	  had	  C.	  difficile	  colitis	  entered	  as	  complaint	  present	  on	  admission	  in	  the	  UNC	  Healthcare	  inpatient	  billing	  data.	  
	   Based	  on	  the	  inpatient	  billing	  data	  and	  the	  assumption	  that	  patients	  are	  prescribed	  antibiotics	  or	  PPIs	  immediately	  upon	  admission	  to	  the	  ICU,	  the	  estimated	  proportion	  of	  high-­‐risk	  patients	  is	  0.7765.	  Based	  on	  estimates	  that	  ~	  2%	  of	  the	  community	  carries	  C.	  difficile	  as	  part	  of	  their	  commensal	  gut	  bacteria,	  this	  results	  in	  the	  following	  admission	  proportions	  for	  each	  patient	  type:	  CP	  =	  0.00447,	  CA	  =	  0.01553,	  UP	  =	  0.209196,	  UA	  =	  0.726804.	  
Relative	  Risk	  of	  CDI	  for	  Patients	  on	  Fluoroquinolone	  and	  PPIs	  
	   While	  many	  models	  assume	  that	  patients	  not	  on	  antibiotics	  or	  PPIs	  are	  incapable	  of	  developing	  CDI,	  the	  model	  in	  Chapter	  5	  assumes	  that	  they	  are	  instead	  at	  a	  significantly	  lower	  risk	  of	  developing	  CDI.	  Based	  on	  a	  number	  of	  meta-­‐analyses53,59,67,	  we	  obtain	  relative	  risks	  (RR)	  of	  1.74	  for	  PPIs	  alone	  and	  3.40	  for	  fluoroquinolone	  alone.	  Assuming	  the	  two	  are	  additive	  on	  the	  log-­‐scale,	  this	  yields	  a	  relative	  risk	  for	  patients	  on	  both	  drugs	  of	  5.92.	  Using	  the	  same	  proportions	  as	  used	  to	  determine	  average	  treatment	  duration,	  the	  log	  weighted	  average	  RR	  for	  a	  patient	  in	  the	  high	  risk	  category	  is	  1.215.	  Exponentiating	  this	  weighted	  average	  RR	  results	  in	  an	  RR	  for	  high-­‐risk	  patients	  of	  3.37.	  	  
Hazard	  of	  Developing	  CDI	  in	  Low-­‐Risk	  Patients	  
	   The	  model	  presented	  in	  Chapter	  5	  had	  a	  single	  unknown	  parameter	  for	  which	  no	  values	  could	  be	  found	  in	  the	  literature	  –	  the	  hazard	  of	  developing	  CDI	  in	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patients	  who	  are	  not	  in	  the	  typical	  risk	  categories,	  such	  as	  those	  on	  antibiotics	  or	  PPIs.	  In	  order	  to	  obtain	  a	  value	  of	  this	  parameter	  that	  results	  in	  a	  level	  of	  infection	  comparable	  to	  that	  of	  the	  experience	  of	  a	  “real	  life”	  hospital,	  the	  model	  was	  fit	  to	  the	  DICON	  surveillance	  time	  series.	  As	  described	  in	  Chapter	  5,	  rather	  than	  fitting	  the	  parameter	  (κ)	  to	  each	  hospital	  series	  and	  then	  attempting	  to	  pool	  those	  estimates,	  	  κ	  was	  fit	  to	  a	  single	  time	  series	  of	  the	  weighted	  average	  cumulative	  incidence	  of	  CDI	  for	  the	  entire	  data	  set.	  The	  best	  fitting	  value	  of	  κ	  was	  found	  by	  minimizing	  the	  sum	  of	  squared	  errors	  between	  the	  time	  series	  and	  the	  predicted	  cumulative	  incidence	  produced	  by	  a	  deterministic	  implementation	  of	  the	  model	  using	  an	  adaptive	  mesh	  refinement	  to	  find	  a	  best	  fitting	  value.	  The	  fit	  between	  the	  data	  and	  the	  best	  fitting	  value	  of	  κ	  is	  shown	  in	  Figure	  A-­‐5.	  
Probability	  of	  a	  Discharged	  Patient	  Developing	  Recurrence	  
	   Estimates	  of	  the	  proportion	  of	  patients	  who	  go	  on	  to	  develop	  recurrence	  vary	  widely	  in	  the	  literature.	  One	  meta-­‐analysis	  suggested	  that	  recurrence	  could	  occur	  in	  10%	  to	  40%	  of	  cases54,	  citing	  previous	  studies	  on	  the	  topic.	  The	  model	  is	  parameterized	  with	  a	  value	  on	  the	  higher	  end	  of	  this	  range	  (0.30).	  Because	  it	  is	  applied	  to	  all	  scenarios,	  the	  specific	  value	  of	  this	  parameter,	  as	  long	  as	  it	  is	  in	  a	  reasonable	  range,	  should	  not	  effect	  the	  results	  of	  the	  modeled	  scenarios	  in	  relation	  to	  each	  other.	  However,	  if	  recurrence	  is	  considerably	  more	  rare,	  it	  may	  be	  more	  difficult	  to	  detect	  a	  significant	  difference	  between	  scenarios,	  as	  model	  realizations	  with	  zero	  recurrent	  cases	  will	  become	  more	  frequent.	  However	  it	  is	  settings	  where	  recurrence	  is	  more	  common	  that	  it	  is	  a	  pressing	  clinical	  concern	  and	  where	  interest	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in	  preventative	  interventions	  is	  more	  active,	  hence	  the	  selection	  of	  a	  parameter	  on	  the	  higher	  end	  of	  the	  range.	  
Probability	  of	  Fecal	  Transplant	  in	  Moving	  Patient	  to	  Low-­‐Risk	  Category	  
	   The	  efficacy	  of	  fecal	  transplant	  was	  estimated	  based	  on	  the	  percentage	  of	  patients	  enrolled	  in	  a	  recent	  clinical	  trial	  who	  were	  cured	  without	  relapse	  after	  one	  or	  more	  infusion	  of	  donor	  feces55.	  We	  assume	  a	  similar	  efficacy	  in	  our	  model,	  where	  93.8%	  of	  patients	  are	  cured	  without	  relapse	  after	  having	  their	  intestinal	  flora	  restored.	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Figure	  A-­‐1.	  Comparison	  of	  density	  functions	  and	  survival	  curves	  for	  an	  empirically	  estimated	  log-­‐normal	  length	  of	  stay	  for	  high-­‐risk	  patients	  without	  CDI	  and	  a	  corresponding	  approximate	  gamma	  distribution.	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Figure	  A-­‐2.	  Comparison	  of	  density	  functions	  and	  survival	  curves	  for	  an	  empirically	  estimated	  log-­‐normal	  length	  of	  stay	  for	  low-­‐risk	  patients	  without	  CDI	  and	  a	  corresponding	  approximate	  gamma	  distribution.	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Figure	  A-­‐3.	  Comparison	  of	  density	  functions	  and	  survival	  curves	  for	  an	  empirically	  estimated	  log-­‐normal	  time	  until	  discharge	  for	  patients	  with	  CDI	  and	  a	  corresponding	  approximate	  gamma	  distribution.	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Figure	  A-­‐5.	  Comparison	  of	  weekly	  weighted	  cumulative	  CDI	  incidence	  time	  series	  from	  31	  hospitals	  in	  the	  Duke	  Infection	  Control	  Outreach	  Network,	  and	  the	  predicted	  cumulative	  incidence	  obtained	  by	  fitting	  a	  deterministic	  model	  of	  C.	  
difficile	  transmission	  to	  this	  data
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